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ABSTRACT 
 
The American University in Cairo 
 
Prediction and Computational Analysis of Novel Chromosomal Type II Toxin Antitoxin 
Systems in the Human Oral Microbiome 
By: Ashraf A. Bazan 
Under supervision of: Dr. Ahmed Abdellatif, Dr. Tamer Salem and Dr. Heba Abostate 
 
 
The importance of the human oral microbiome is progressively receiving considerable attention in 
recent research, serving as a model niche for studying microevolution. The impact of horizontal 
gene transfer by mobile genetic elements in such environment is the driving force for the mosaic 
nature of the oral microbiome. However, there is a missing link between the molecular systems 
interactions responsible for the plasticity of the genomes and the adaptations of the oral 
microbiome to physiological and pathological changes. The mobile chromosomal type II Toxin 
Antitoxin Systems (TASs). are known for their effective role in dynamic environment adaptation 
and stress response. In this study, we predicted and analyzed the genetic diversity and evolution 
of type II TAS in the oral microbiome of an Egyptian, presumably healthy, individual. 16S rRNA 
sequencing (submitted to GenBank). showed taxonomic analysis and microbial diversity and 
species abundance in three samples of supragingival plaque, subgingival plaque and buccal 
mucosa. Two hundred and seventy-eight type II TAS were identified from sequenced 
chromosomal genomes of the oral microbiome by means of exhaustive sequence and 3D structure 
homology, Hidden Markov Modelling and manual domain analysis. Gene family assignment were 
proposed since majority of the genes were previously annotated as hypothetical proteins. TAS 
network of the oral microbiome showed highly interconnected centralities which entails the 
extensive cross talk and intra-regulatory nature. Molecular ecology analysis of the type II TAS 
using diversity indexes confirms both diversity and relative abundance of these systems in the oral 
microbiome. Molecular evolutionary phylogenetic maximum likelihood analysis of the type II 
TAS, using modified Whelan And Goldman (WAG) as best fit evolution model, was performed 
for the predicted toxin antitoxin systems. Further analysis revealed evidence for the persistence of 
the toxin antitoxin systems throughout the oral microbiome. Molecular allometric analysis 
confirms uneven persistent distribution of the type II TAS. This comprehensive study of new 
chromosomal type II toxin antitoxin systems found in the oral microbiome provides insights on 
plasticity of the human oral microbiome and its adaptation to change in the host environment.  
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1. LITERATURE REVIEW 
1.1. Human Oral Microbiome 
1.1.1. Introduction on Human Oral Microbiome 
Since its inception, microbiology has focused on the human oral “Animalcules” as 
described by the very first scientist Antonie van Leeuwenhoek to discover microbes (Gest, 2004; 
Leeuwenhoek Antoni Van, 1677) Since then, it has been of great interest to study the human oral 
microbiome for reasons of easy accessibility, understanding diseases pathophysiology and 
studying host – microbe ecology to name a few (Dewhirst et al., 2010) Before the advent of the 
culture-independent analysis methods, most the studies were focusing on culturable microbes; 
however, recently, the focus has shifted toward a holistic view of the oral microbiome (Verma, 
Garg, & Dubey, 2018) 
The complex system biology of the oral microbiome includes strikingly important cues for 
both the diversity and richness of the Operational Taxonomic Units (OTUs) of the regional 
ecosystem, where its evolutionary dynamics changes promptly to ecological inter and intra-species 
interactions including that of the host physiology and/or pathology (Krishnan, Chen, & Paster, 
2017)  Recognizing the extensive form and the non-zero-sum nature of the oral microbiome, the 
research has been reformed to study the elements of the system differently. Studying the 
interactions of the microbes alongside the molecular systems of these microbes holds informative 
and divergent ingenuity to understand short-comings of reductionist approach in understanding 
clinical diseases etiology and molecular biology (Cross et al., 2018; Edlund et al., 2013, 2015; Pál 
& Papp, 2017)  A prime example for this is the dental caries, where it was believed for centuries 
that Streptococcus mutans is the sole cause of the condition. Currently, it is evident that the 
instability of the composition of the dental biofilm is what aggravate the periodontitis and dental 
caries (Bowen, Burne, Wu, & Koo, 2018; McLean, 2014) Another solid example for the holistic 
approach used in the oral microbiome research is the discovery of the mechanism of action and 
the evolution patterns of the miropin, a serpin-type suicidal endopeptidase inhibitor, found in the 
metagenome of the human oral microbiome (Goulas et al., 2017) 
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This approach has revolutionized the research where our fundamental understanding of the 
ecology, evolution and clinical diseases is more rationally restructured, yet, incompletely resolved 
and leave us with questions more than answers.  
1.1.2. Ecology of the Human Oral Microbiome 
The human oral microbiome is the second largest microbial community right after the gut 
microbiome. The expanded Human Oral Microbiome Database (eHOMD) contains, as of April 
2019, seven hundred and seventy-two different species (Chen et al., 2010; Human Microbiome 
Project Consortium, 2012; Verma et al., 2018) Although the salivary microbiome is considered 
broadly stable throughout different states, it is just a collection of planktonic microbes shredded 
from different sites in the buccal cavity (Belstrøm et al., 2016) The abundance and diversity varies 
in the oral microbiome of the buccal mucosa, hard palate, masticator mucosa, soft palate, different 
teeth enamels, supragingival tract, subgingival tract, tongue dorsum, keratinized gingiva and 
palatine tonsils (Moon & Lee, 2016)  
The human oral microbiome has nearly third of the taxa unculturable. The culturable taxa 
can be broadly categorized into six phyla, namely, Actinobacteria, Bacteroidetes, Firmicutes, 
Fusobacteria, Proteobacteria and Spirochetes (Palmer, 2014; Verma et al., 2018) According to 
the updated eHOMD, the most abundant phylum is the Firmicutes, followed by Bacteroides 
(Dewhirst et al., 2010) However, false positives of taxonomic assignments are present due to 
Operational Taxonomic Units (OTU) similarity bias to the overrepresented Firmicutes in the 
databases used in the analysis. On the genus level, the most common are the Streptococcus and 
Veillonella. The major genera found are those of the Actinomyces, Corynebacterium, Rothia, 
Capnocytophaga, Prevotella, Haemophilus, Granulicatella and Neisseria. All of these constitute 
what is called the core oral microbiome because of their abundance. On the other hand, the variable 
oral microbiome is formed by the fluctuations of several other genera depending on the niche 
conditions (Verma et al., 2018; Zaura, Keijser, Huse, & Crielaard, 2009)  
There are different niches in the buccal cavity which can be categorized into saliva, dental 
plaque and buccal mucosa. As mentioned above, whatever shed from the biofilms of the mucosa 
or plaque would be in the saliva in the plankton form. It has been estimated that there are around 
140 million CFU/ml of the saliva. The major constituents of the salivary microbiome are 
Actinobacteria, Bacteroides, Firmicutes, Fusobacteria, Proteobacteria, Spirochetes, and TM7  (J. 
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He, Li, Cao, Xue, & Zhou, 2015; Human Microbiome Project Consortium, 2012; Zaura et al., 
2009) The microbiome of the dental plaque forms biofilm on the teeth surface (L. Yang et al., 
2011) Although the microbial community may vary based on which tooth, the main variation in 
the dental plaque biofilms is between the supragingival plaque and the subgingival plaque with the 
supragingival microbiome being more rich and diverse (Filoche, Wong, & Sissons, 2010; Gross et 
al., 2010; J. He et al., 2015; Keijser et al., 2008) Conversely, the buccal mucosa microbiome has 
lower diversity profile. The tongue dorsum is being extensively studied for research on halitosis. 
The characterized microbes of the tongue that are abundant include Streptococcus salivarius and 
Rothia mucilaginosa (J. He et al., 2015; Kazor et al., 2003)  
In addition to the traditional bacterial phyla, there is a group of bacteria lineages that are 
extremely small in shape and genome size compared to most bacterial lineages. They are termed 
Candidate Phyla Radiations (CPRs) (Hug et al., 2016) The CPRs have provocative interspecies 
interactions that largely shapes the ecology of the oral microbiome. This newly categorized group 
is huge, consisting of around 15% of the bacterial domain with around 70 different phyla. 
Interestingly, they have less functional diversity and minimal metabolome, thus leading to the 
inference of being some sort of parasitic organisms (Danczak et al., 2017) Although they harbor 
the archaeal enzyme RubisCO that is used in carbon dioxide fixation, they are well-known obligate 
symbiont dependent on other bacteria (Baker, Bor, Agnello, Shi, & He, 2017; Wrighton et al., 
2016) One of the best studied CPRs is the TM7x (Kianoush et al., 2014; Segata et al., 2012; Soro 
et al., 2014; Zhou et al., 2013). Under different physiological and environmental conditions, it can 
significantly alter the whole oral habitat ecosystem through its multivariate interactions with other 
species especially those of the Actinomyces (X. He et al., 2015; McLean et al., 2016) The 
abundance of such organisms increases from around 1% to approximately 21% of all of the 
microbiome in oral diseases such as periodontitis (B. Liu et al., 2012; Rylev, Bek-Thomsen, 
Reinholdt, Ennibi, & Kilian, 2011) Besides, they can expressively modify host immune responses, 
such as, macrophages response, cytokines concentrations and TNF-α inhibition (X. He et al., 2015) 
Thus, the dynamic ecology of the buccal cavity is more than just the richness, but also, the 
interactions within and between species. 
Indeed, The human oral microbiome is more than just the bacteriome. In fact, there are 
about more than 100 species of known fungi that resides in the oral cavity (Bandara, Panduwawala, 
& Samaranayake, 2019; Dupuy et al., 2014; Ghannoum et al., 2010; Peters, Wu, Hayes, & Ahn, 
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2017) The oral mycobiome has low abundance compared to the oral bacterial communities (Baker 
et al., 2017); however, the impact should not be underestimated. This is because of two reasons; 
firstly, Despite the fungal communities low abundance, the larger fungal cell sizes constitutes a 
larger biomass in the oral ecosystem (Cui, Morris, & Ghedin, 2013) Secondly, hyphens of the 
fungi formulates backbone for the formation of multi-species biofilm (Baker et al., 2017) The 
medical impact of the fungi on the host is, clearly, huge. This is evident as clinicians encounters 
several fungal infections from local candidiasis to lethal systemic infections (Cui et al., 2013; 
Samaranayake, 2018) The mycobiome has massive inter-kingdom communication that is regarded 
as keystone species. For example, Candida albicans virulence is orchestrated with a handful of 
bacterial species like Streptococcus mutans, Streptococcus oralis and Fusobacterium nucleatum. 
On the other hand, biofilm formation abilities of such bacteria are reformed when interacting with 
Candida albicans (Allison et al., 2016; Baker et al., 2017; Diaz, Strausbaugh, & Dongari-
Bagtzoglou, 2014; Janus, Willems, & Krom, 2016) We can infer from the Candida albicans 
interactions the importance of the oral mycobiome ecology (Bandara et al., 2019) 
The virome of the oral microbiome is unique for individual hosts (Abeles et al., 2014; 
Naidu, Robles-Sikisaka, Abeles, Boehm, & Pride, 2014; Pérez-Brocal & Moya, 2018; Pride et al., 
2012) Most of the virome are bacteriophages, mostly, the Myoviridae, Podoviridae and 
Siphoviridae families (Pérez-Brocal & Moya, 2018; Pride et al., 2012) The most abundant 
eukaryotic virus in the oral cavity is human Herpesviridae followed by Papillomaviridae and 
Anelloviridae(Baker et al., 2017; Pérez-Brocal & Moya, 2018) Beguilingly to explore, the 
extensive co-evolution, complex adaptation and exaptation of mobile genetic element is believed 
to modulate the ecology of the oral microbiome, which results in what has recently been termed 
“Ecological Diseases.” (Hoare, Marsh, & Diaz, 2017)  
1.1.3. Association of Human Oral Microbiome and Clinical Diseases 
The healthy oral ecosystem is personalized. Nevertheless, it is, also, considered allostatic 
in the normal physiology of the host. This happens when dynamic interactions among elements of 
the microbiome and the host attain a homeostasis that can actively adapt to changing conditions in 
the oral cavity (Zaura & Cate, 2015) Accordingly, dysbiosis of the human oral microbiome is 
defined as failure of the host or microbial communities to adapt to the changing physiology of the 
buccal cavity. Dysbiosis of the human oral microbiome is statistically associated with various 
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clinical diseases which raise questions, not only for the causality predicament, but also the 
fundamental etiology of the diseases and, thereby, possibilities for effective treatment. The 
diseases could be categorized into two categories: oral diseases and systemic diseases.  
Oral disease includes caries, periodontal diseases, mucosal diseases and oral cancer. 
Systemic diseases include a plethora of gastrointestinal diseases, such as, irritable bowel 
syndrome, neurological diseases like Alzheimer’s disease, endocrine diseases, such as, obesity, 
immunological diseases, such as, Rheumatoid Arthritis and cardiovascular diseases, such as, 
atherosclerosis. All of which have significant skew in the microbial communities in the 
polymicrobial biofilms on different buccal sites suggesting strong association and, surprisingly, 
causation of molecular etiology. These diseases are reviewed elsewhere as being out of the thesis’s 
scope (Bowen et al., 2018; Cong & Zhang, 2018; L. Gao et al., 2018; Healy & Moran, 2019; Verma 
et al., 2018; Yangheng Zhang et al., 2018) 
1.1.4. Mobile Genetic Elements as Key Members of the Human Oral Microbiome 
Vital members of the human oral microbiome, yet understudied in this context, are the 
Mobile Genetic Elements (MGEs). The human oral microbiome has remarkable interplay among 
its elements at both the inter-genome and intra-genome levels. The biology of the mobile genetic 
elements is a key player in understanding the ecology, evolution and host response to the oral 
microbiome (Koonin Eugene V., 2016) The mobile genetic elements include integrative 
conjugative elements (ICE), transposons, group I and II introns, phages, prophages, plasmids, 
Insertion Sequence (IS) elements, Genomic Islands (GI), pathogenicity islands and selfish 
elements (Frost, Leplae, Summers, & Toussaint, 2005; Koonin Eugene V., 2016) 
Most of the virome are bacteriophages living through most phyla of the oral bacteria 
(Pérez-Brocal & Moya, 2018; Pride et al., 2012) Both lysogenic prophages and lytic phages 
develop both adaptive and antagonized co-evolutionary red queen dynamics of the host bacteria  
(Baker et al., 2017; Fernández, Rodríguez, & García, 2018; Wahida, Ritter, & Horz, 2016; Yutin 
et al., 2018) Recently, there have been evidence of microbiome bacteriophages interacting with 
human mammalian cells albeit in vitro (Kaźmierczak & Dąbrowska, 2018) Beyond phages, the 
extensive horizontal gene transfer in the oral niche is predominantly central as the oral microbiome 
is primarily polymicrobial biofilm that facilitates exogenous flow of DNA (Bowen et al., 2018; 
Pinilla-Redondo, Cyriaque, Jacquiod, Sørensen, & Riber, 2018)  
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Horizontal Gene Transfer (HGT) provides augmented phenotype diversification upon co-
evolution of the oral microbiome. This diversification outnumbers gene duplication leading to 
extensive co-speciation via elevated fitness cost of independent evolution (Shropshire & 
Bordenstein, 2016; Treangen & Rocha, 2011) The mosaic plastic nature of the bacterial 
communities enables release, passage and uptake of DNA – and more recently RNA – within and 
between species and kingdoms (Smillie et al., 2011) This communication of genotype occurs 
through different vehicles from secretion systems and integrative conjugative elements to, the 
newly discovered, bacterial nanotubes, viral-like gene transfer agents and membrane vesicles 
(Brimacombe, Ding, Johnson, & Beatty, 2015; Broaders, Gahan, & Marchesi, 2013; Dorward, 
Garon, & Judd, 1989; Dubey & Ben-Yehuda, 2011; Klieve et al., 2005; Koonin, 2016; Marrs, 
1974; Wagner et al., 2017) Astonishingly, these transfers occur by unexpected rate and extent that 
reach estimates of 20% of the rate of point mutations (Vos, Hesselman, Te Beek, van Passel, & 
Eyre-Walker, 2015) It was calculated that on average there is 43.9 HGT event occur per one 
microbe in the human microbiome, at the time of the study. Thus, the whole human holobiont is 
considered a hotspot for HGT (L. Liu et al., 2012; Rosenberg & Zilber-Rosenberg, 2018) A study 
was conducted on human gut microbiome to analyze the HGT extent. By the compositional 
methods of calculating signature GC content, they found that up to 6.5% of all Open Reading 
Frames (ORFs) of all of the microbiome occurred by HGT (Sitaraman, 2018; Tamames & Moya, 
2008) 
Diving into the effector mechanisms for the host modulation of the HGT, the Cationic Anti-
Microbial Peptides (CAMPs) of the innate immune system delivers a constant stress pressure on 
the microbial communities that collaterally empowers HGT events. This empowers evolutionary 
pathways required for adaptation (Andersson, Hughes, & Kubicek-Sutherland, 2016; Cullen et al., 
2015; Wimley, 2010) Thus, HGT promotes resilience against host perturbations viciously allowing 
for numerous cascades like persistence until fitness adaptation, virulence to the host and resistance 
to host xenobiotics with quorum sensing orchestrating such endeavors among the microbiome 
population (Ferreiro, Crook, Gasparrini, & Dantas, 2018) This gave rise to what is known as 
microbiome-derived resistome (Adu-Oppong, Gasparrini, & Dantas, 2017, p.; Crofts, Gasparrini, 
& Dantas, 2017) Different physiology and conditions of the host affects the HGT-mediated 
evolution of the microbiome such as host diet, heavy metal exposure and antibiotic chemotherapy 
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exposure (Ferreiro et al., 2018) This is a classic example of how elements of ecosystem evolve to 
escape local fitness optima in the ecological stability landscape. (Pál & Papp, 2017)  
On another front, pitching on the HGT among the microbiome, it is noticeable the extensive 
evolutionary conflicts within individual microbe genome, among members of the same species, 
between different species, genera and, even, kingdoms (Ferreiro et al., 2018; Pinilla-Redondo et 
al., 2018) Certain communities of the oral microbiome produce bacteriocin that poses stress on 
other communities nearby (Burton et al., 2013; Hasannejad Bibalan, Eshaghi, Rohani, Pourshafie, 
& Talebi, 2017) The dental biofilm members Streptococcus mutans, Streptococcus gordonii and 
Streptococcus salivarius produce bacteriocins that negatively impact other species but itself. This 
is due to acquisition of several Integrative Conjugative Element (ICE) that codes for bacteriocin 
and its immune protein. Co-cultures of the two species mentioned above are capable of 
communicating and distributing the bacteriocin ICE. However, the other species in the community 
are susceptible to bacteriocins (Dahmane et al., 2017; Kreth, Merritt, Shi, & Qi, 2005; Mignolet et 
al., 2018) Another example is the bacteriolytic elements produced by the Type VI Secretion 
Systems in the ICE harbored by some species of the oral microbiome. This lysis occurs mainly for 
exogenous genetic uptake essential for competence in adaptive evolution as well as nutrition  
(Borgeaud, Metzger, Scrignari, & Blokesch, 2015; Coyne, Roelofs, & Comstock, 2016; Finkel & 
Kolter, 2001)  
In the arm race between the microbiome, there are several systems that interplay in the 
evolutionary conflicts driving adaptation (McLaughlin & Malik, 2017) They are protection 
mechanisms for the genome if required. Model examples are the Restriction Modification (RM) 
systems and the CRISPR-Cas systems. A supporting example is the CRISPR-Cas system in 
periodontal biofilm bacteria Aggregatibacter actinomycetemcomitans that increases the 
transformability and cell competence in the oral microbiome thereby driving diversity (Jorth & 
Whiteley, 2012) Although both RM and CRISPR-Cas systems are being horizontally transferred, 
they operate as checkpoints for mobile genetic elements disseminating harmful horizontal gene 
transfer events to attain genome stability (Furuta, Abe, & Kobayashi, 2010; Kobayashi, 2001) Both 
are key players in HGT of the human oral microbiome.(Sitaraman, 2018) 
The study of mobilome of the oral microbiome is still in its infancy (Martínez, 2018; 
Sitaraman, 2018) Although there have been several studies on the horizontal gene transfer events 
in the oral microbiome, several questions remained unanswered, such as, how these mobile genetic 
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elements shape and “quorum-sense” communities as biofilms collaborating virulence and 
antibiotic resistance genes on the system level (Ferreiro et al., 2018) There are investigations on 
how phages and exogenous genes are invited or fought against depending on the need or the fitness 
cost. Studies attempted to explore mobile genetic elements that alleviate conflict molecular 
systems are insufficient to draw conclusive answers (Fernández et al., 2018) As being understudied 
in the human oral microbiome, it came clear that one molecular system holds a common role as 
described in the above questions; it suggests the chromosomal type II toxin antitoxin systems.  
1.2. Toxin Antitoxin Systems 
1.2.1. Introduction on Toxin Antitoxin Systems 
The Toxin Antitoxin (TA) system appeared first in the literature in 1997 by Martin Holčík 
and V. M. Iyer (Holcík & Iyer, 1997)They categorized the post segregational killing effect of two 
components gene operons and labeled them as being a Toxin Antitoxin Systems (TAS). The first 
described TAS operon was in 1985 by Kenn Gerdes and colleagues (K Gerdes, Rasmussen, & 
Molin, 1986) They described a novel mechanism of plasmid maintenance in the population of 
Escherichia coli. At that time, it was known that the only plasmid maintenance mechanism is the 
partitioning system, which was less efficient with plasmids of low copy number as the bacterial 
replication could overwhelm the low copy numbered plasmids leading to limited partitioning. 
Additionally, several plasmids lack the partitioning system genes (Guynet & de la Cruz, 2011) 
Although the “Pilot-Fish” – like mechanism could drive the plasmid maintenance in such 
Partitioning – lacked plasmids, a negative selection hypothesis were believed to take place (Ogura 
& Hiraga, 1983) Gerdes group discovered the hok/sok system in the R1 plasmid that could apply 
a conditional negative selection pressure on plasmid-free cells; this is to say, the hok/sok system 
is killing of the plasmid free segregated cells (K Gerdes, Bech, et al., 1986) 
Since then, the Post Segregation Killing (PSK) effect of several genes has been described 
in different plasmids which lead to their annotation by Holcík group as Toxin Antitoxin System. 
This is due to their neat molecular mechanism that involves two components: a stable toxic 
component that is rescued by a continuously expressed cognate antidote (Figure 1-1). Thus, in the 
progeny of mother cells, the labile antitoxin of lower half-life time than the toxin should be 
continuously expressed on the plasmid segregated cells, while the stable toxin is inherited through 
the cytoplasmic partitioning during replication. If the daughter cells are deficient of the plasmid, 
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the antitoxin will be depleted at a higher rate than the toxin leading to killing of the plasmid-less 
daughter cells.     
    
Figure 1-1: A cartoon diagram representing the basic idea of post segregation killing (PSK). of 
plasmid-less bacterial cells. The toxin (denoted as red dots) is expressed from the plasmid and 
inherited from the mother to daughters as they have high half-life time. On the contrary, the 
antitoxin (denoted as black dots) requires continuous expression from the plasmid; that is, the 
plasmid must be inherited for the daughter cell to survive the inherited toxin. 
1.2.2. Classification of the Toxin Antitoxin Systems.  
The Toxin Antitoxin Systems could be classified structurally and mechanistically. The 
common classification of the TAS is that according to the mechanisms of the neutralization of the 
antitoxin to the toxin. In that manner, the TAS has been recently categorized into seven types  
(Harms, Brodersen, Mitarai, & Gerdes, 2018a; Walling & Butler, 2019) On the other hand, the 
TAS families under each type are further classified based on the structural differences. This 
classification is sensible; as the mechanisms of action of the TAS has prominent association with 
their evolutionary patterns and abundance throughout the three life domains. Besides, structural 
homology is minimal between different mechanistic types of the TAS. Although there is a quite 
debate on the functions of the TAS, certain functions are allocated to certain types of the TAS 
which makes it more meaningful to classify the TAS according to the mechanisms of 
neutralization. Holistically, the antitoxins are proteins in case of types II, IV, V, VI and VII. In 
types I and III, the antitoxin are small RNAs (Goeders & Van Melderen, 2014; Page & Peti, 2016; 
Song & Wood, 2018a)  
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1.2.2.1. Type I Toxin Antitoxin Systems.  
This type of the TAS has the active toxin in a protein form. However, the antitoxin is a 
small antisense RNA that binds to the toxin’s mRNA and hinder its translation (Fozo, Hemm, & 
Storz, 2008; Kenn Gerdes & Wagner, 2007) The toxin protein is a small hydrophobic protein with 
a mechanism that is not-fully understood; however, it is believed to increase the cellular membrane 
potential through depolarization (K Gerdes, Bech, et al., 1986; Ono, Akimoto, Ono, & Ohnishi, 
1986; Weaver et al., 2003) The Type I Toxins have transmembrane domains much like several 
antimicrobial peptides albeit here the toxic effect is self-destructive (Arnion et al., 2017; 
Henriques, Melo, & Castanho, 2006; Unoson & Wagner, 2008) As for the antitoxin, the regulation 
of the toxins is through direct binding to the ribosomal binding site by simple base-pairing.  
Although this is not the case for the most studied case of Type I Toxin Antitoxin System, the 
Hok/Sok system, some antitoxins bind to the mRNA of the toxins in other sites blocking standby 
ribosomes (Fozo et al., 2008; Reif, Löser, & Brantl, 2018) It is evident that the type I Toxin 
Antitoxin Systems are usually in tandem repeat. The chromosomal TAS in this type are known to 
be laterally transferred. This could limit its breadth of taxonomic distribution; nonetheless, it is 
merely apparent to be increasingly abundant (Coray, Wheeler, Heinemann, & Gardner, 2017; Fozo 
et al., 2010) 
1.2.2.2. Type II Toxin Antitoxin Systems. 
The Type II Toxin Antitoxin Systems are the most studied of the Toxin Antitoxin Systems. 
Both the toxin and the antitoxin are protein in nature. The type II toxins are small in size and have 
a large variety of target molecules. On the other hand, the type II antitoxins neutralize the toxin 
proteins. They, mainly, possess two domains; (1) DNA Binding Domain and (2) Protein 
Interacting Domain.  The type II antitoxin proteins neutralize the toxin proteins by two main 
mechanisms; (1) They have direct interaction to the toxin protein through the C – terminal toxin 
binding domain and (2) the toxin-antitoxin complex exposes the N – terminus of the antitoxin and 
binds to the promoter of the Toxin Antitoxin Operon repressing the expression of the toxin. The 
DNA Binding Domain at the N – terminus is also responsible for the vast regulatory roles of the 
type II antitoxins that will be discussed below. The structure of the antitoxin is readily distorted 
exposing itself for proteolysis (Harms et al., 2018a; Makarova, Wolf, & Koonin, 2009a; Xia, Bao, 
Zhang, Linhardt, & Liang, 2019) 
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The Type II Toxin Antitoxin Systems can be sensu lato classified further into families. 
There are two systems for classification of Type II Toxin Antitoxin Systems. One that is based on 
toxin protein sequence similarity and the other is based on the domains of the toxin antitoxin 
systems independent from the proteins they are homologous to (Kenn Gerdes, Christensen, & 
Løbner-Olesen, 2005; Van Melderen & Saavedra De Bast, 2009) 
The classification based on the toxin amino acid similarity is presented in the (Table 1-1) 
which embodies the 14 Toxin Antitoxin Systems super families. Eleven of which are of two 
components, which are the toxin and the antitoxin. They are the super families: ccd, HicBA, 
HipBA, mazEF(chpA), parD (PemKI), parDE, phd-doc, relBE, vapBC (vag), mosAT and yeeUV.  
Three of the TAS super families are three component systems, having a regulator beside the toxin 
and antitoxin genes as will be discussed below in the regulation section. These super families are 
Omega Epsilon Zeta (ω-ε-ζ), pasABC and paaR-paaA-parE.  
It was suggested to categorize the type II toxins super families and Type II antitoxins super 
families separately because of the extensive cross talk between the members of each super families 
in “mix and match” phenomenon (Leplae et al., 2011) 
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Table 1-1: The Type II Toxin Antitoxin Systems Classification according to toxin protein sequence 
similarity. 
TAS 
SuperFamily 
TAS 
SubFamily 
Toxin 
Component 
Antitoxin 
Component 
Reference* 
Ccd -  COG5302 CcdA (De Jonge et al., 
2010; Wilbaux, 
Mine, Guérout, 
Mazel, & Van 
Melderen, 2007) 
pfam01845 
CcdB 
 
 pfam07362 
CcdA 
 COG3609 
HicBA -  COG4226 HicB (Jørgensen, Pandey, 
Jaskolska, & Gerdes, 
2009; Makarova, 
Grishin, & Koonin, 
2006) 
 pfam05534 HicB 
 COG1598 
COG1724  
HipBA -  COG1396 HipB (Black, Irwin, & 
Moyed, 1994; Moyed 
& Bertrand, 1983; 
Rotem et al., 2010) 
HipA  
mazEF 
(chpA). 
-  COG2002 AbrB (Aizenman, 
Engelberg-Kulka, & 
Glaser, 1996; 
Engelberg-Kulka et 
al., 1998; Syed et al., 
2011) 
 COG2336 MazE 
COG2337 MazF  
pfam02452 
PemK 
 
 pfam04014 
AbrB 
parD 
(PemKI). 
- Kid (PemK).  (Kamphuis et al., 
2007; Monti et al., 
2007) 
 Kis (PemI). 
parDE - COG3668 ParE  (Easter, Sobecky, & 
Helinski, 1997;  COG3609 
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TAS 
SuperFamily 
TAS 
SubFamily 
Toxin 
Component 
Antitoxin 
Component 
Reference* 
Yuan, Yamaichi, & 
Waldor, 2011) 
phd-doc - COG3654 Doc  (Garcia-Pino, 
Sterckx, 
Vandenbussche, & 
Loris, 2010; Gazit & 
Sauer, 1999; 
Lehnherr, Maguin, 
Jafri, & 
Yarmolinsky, 1993) 
 COG4118 Phd 
pfam05012 Doc  
relBE higBA  cd00093 
HTH_XRE 
(Arbing et al., 2010; 
Tian, Ohnishi, 
Tabuchi, & 
Terawaki, 1996) 
COG3549 HigB  
COG3550 HipA  
 COG4691 StbC 
 smart00530 Xre 
pfam05015  
 pfam01381 
HTH_3 
relBE COG2026 RelE  (Grønlund & Gerdes, 
1999; Han et al., 
2011) 
 COG2161 StbD 
 pfam04221 RelB 
 COG3609 
pfam05016  
yefM-yoeB YoeB  (Christensen et al., 
2004; Yonglong 
Zhang & Inouye, 
2009) 
 YefM 
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TAS 
SuperFamily 
TAS 
SubFamily 
Toxin 
Component 
Antitoxin 
Component 
Reference* 
ygiTU 
(mqsAR). 
MqsR (YgiU).  (Kasari, Kurg, 
Margus, Tenson, & 
Kaldalu, 2010; Kim 
et al., 2010) 
 MqsA (YgiT). 
prlF-yhaV YhaV  (Schmidt et al., 2007) 
 PrlF 
VapBC (vag). -  cd00093 
HTH_XRE 
(Arcus, McKenzie, 
Robson, & Cook, 
2011; Bloomfield, 
Whittle, McDonagh, 
Katz, & Cheetham, 
1997; Cooper, 
Daugherty, 
Tachdjian, Blum, & 
Kelly, 2009) 
VapC  
 COG2002 AbrB 
 COG3093 VapI 
 COG4456 VagC 
pfam01850 PIN  
 pfam04014 
AbrB 
 smart00530 Xre 
COG1848  
 COG3609 
COG4113  
 COG4423 
 pfam01381 
HTH_3 
mosAT - cl00973 
DUF1814 
 (Wozniak & Waldor, 
2009) 
 pfam11459 
DUF2893 
yeeUV - yeeV  (Brown & Shaw, 
2003)  yeeU 
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TAS 
SuperFamily 
TAS 
SubFamily 
Toxin 
Component 
Antitoxin 
Component 
Reference* 
ω-ε-ζ 
(PezAT). 
- ζ zeta  (Mutschler, 
Reinstein, & 
Meinhart, 2010; 
Zielenkiewicz & 
Ceglowski, 2005) 
 ε epsilon 
  
pasABC - PasB  (Matcher & 
Rawlings, 2009; 
Smith & Rawlings, 
1998) 
 PasA 
  
paaR-paaA-
parE 
- ParE  (Hallez et al., 2010) 
 PaaA 
  
*Representative bibliography is only mentioned in this table. 
 
The other classification system for type II Toxin Antitoxin Systems is according to the 
TAS domains. This domain-based classification is suggested by Makarova et al. (Makarova et al., 
2009a) The reason behind this classification is that it is flexible to accommodate novel Toxin 
Antitoxin Systems that are predicted computationally, since there are a lot of interplay and cross 
talk between domains of different TAS super families of the previous classification (Goeders & 
Van Melderen, 2014) The list of Toxin Antitoxin domains is presented in (Table 1-2) and it has 
been concatenated by developers of the Toxin Antitoxin DataBase (TADB) (Xie et al., 2018a)  
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Table 1-2: Domain-based Classification of the Toxin Antitoxin Systems 
TA pair T-domain AT-domain 
Xre-HipA HipA Xre 
Xre-COG5654 COG5654 Xre 
Xre-COG2856 COG2856 Xre 
Xre-Bro Bro Xre 
Xre-YgiU YgiU Xre 
Xre-DUF397 DUF397 Xre 
Xre-Fic Fic Xre 
Xre-PIN PIN Xre 
Xre-MazF MazF Xre 
Xre-GNAT GNAT Xre 
Xre-RelE RelE Xre 
COG5606-RelE RelE COG5606 
RHH-RelE RelE RHH 
AbrB-RelE RelE AbrB 
PHD-RelE RelE PHD 
RHH-COG2929 COG2929 RHH 
RHH-GNAT GNAT RHH 
RHH-Fic Fic RHH 
RHH-PIN PIN RHH 
RHH-MazF MazF RHH 
XF1863-MazF MazF XF1863 
PHD-MazF MazF PHD 
AbrB-MazF MazF AbrB 
AbrB-Fic Fic AbrB 
AbrB-PIN PIN AbrB 
MerR-PIN PIN MerR 
COG2442-PIN PIN COG2442 
COG2886-PIN PIN COG2886 
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TA pair T-domain AT-domain 
PHD-PIN PIN PHD 
PHD-Fic Fic PHD 
HicB-HicA HicA HicB 
HEPN-MNT MNT HEPN 
ArsR-COG3832 COG3832 ArsR 
YhfG-Fic Fic YhfG 
Xre-COG3832 COG3832 Xre 
COG2886-RelE RelE COG2886 
Xre-COG2929 COG2929 Xre 
COG5304-COG2929 COG2929 COG5304 
PHD-MazFn MazFn PHD 
COG1753-PIN PIN COG1753 
COG2880-PIN PIN COG2880 
PHD-SMa0917 SMa0917 PHD 
COG5606-COG4679 COG4679 COG5606 
COG5642-COG5654 COG5654 COG5642 
1.2.2.3. Type III Toxin Antitoxin Systems. 
The third type of the Toxin Antitoxin systems has the antitoxin in form of sRNA that 
interact with the proteinaceous toxin. What distinct this type of the TAS is their unusual 
stoichiometry of the RNA-Protein interaction (Goeders, Chai, Chen, Day, & Salmond, 2016) The 
Type III TAS cassettes are bicistronic operon with the antitoxin composed of several repeats of 
short nucleotide sequences. The toxin protein processes this sRNA into monomers of these repeats 
forming dynamic complexes of the toxin interacting with one or more of the antitoxin monomers 
(Short et al., 2013) Although the half life time of the antitoxin is relatively higher than the other 
TAS types, the antitoxin can neutralize several toxins via the monomers. Also, the genetic 
organization of the type III operon contains intra-genetic Rho independent terminator which 
favours the antitoxin expression over the toxin protein (Rao et al., 2015) Under stress condition, 
the antitoxin half-life is shorter than the toxin protein; therefore, it survives and out paces the 
antitoxin interactions in a fashion not fully understood (Goeders et al., 2016) 
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 The most common families of the type III TAS are the TenpIN, CptIN and ToxIN (Blower 
et al., 2012) In spite of some sequence homology with the type II TAS, the families of type III do 
not cross talk with each other or with other types of TAS. This could be due to the distinct 
pseudoknots the sRNA of the antitoxins form that differ in each family of the type III TAS  (Short 
et al., 2013) Besides its function as addiction module, the characteristic role of the type III TAS is 
the antiviral abortive infection systems. Unlike the CRISPR and the Restriction Modification 
systems that solely protects the bacterium cell, the abortive infection systems perform “altruistic 
suicide” to protect the population of the colony (Short, Akusobi, Broadhurst, & Salmond, 2018) 
1.2.2.4. Type IV Toxin Antitoxin Systems. 
Both the toxin and the antitoxin of this poorly studies type of the TAS are protein in nature. 
In this type, the antitoxin interacts with the target of the toxin protecting it from the poisonous 
activity of the toxin. Thus, there is no direct interaction between the toxin and the antitoxin; 
instead, each independently acts on the target (Masuda, Tan, Awano, Wu, & Inouye, 2012; 
Zhongling Wen, Pengxia Wang, Chenglong Sun, Yunxue Guo, & Xiaoxue Wang, 2017) The 
vastly studied example is the cbeA/cbtA system (formerly known as YeeUV system), in which the 
target is the MreB/FtsZ proteins of the bacterial cytoskeleton. The toxin cbtA stalls the 
polymerization leading to fatal wobbly cell wall; on the other hand, the antitoxin promotes polymer 
bundling (Brown & Shaw, 2003) 
1.2.2.5. Type V Toxin Antitoxin Systems. 
The type V Toxin Antitoxin Systems are discovered in 2012 as Page and Wood group 
analyzed the GhoST system. It is established as a novel type of Toxin Antitoxin System as the 
antitoxin mechanism of neutralization is unique. The type V antitoxins are ribonucleases that 
specifically targets the mRNA of the toxin (Wang et al., 2012) 
1.2.2.6. Type VI Toxin Antitoxin Systems. 
The ClpXP proteases are potent proteolytic systems that can act on the type VI toxin 
proteins after being activated by the type VI antitoxin proteins. The antitoxins are, thus, adaptors 
that affects the toxin proteins indirectly through Clp-facilitated pathway. This indirect inhibition 
of the antitoxin is the reason to categorize these systems as an atypical type of TAS, namely, type 
VI toxin antitoxin systems (Aakre, Phung, Huang, & Laub, 2013) 
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1.2.2.7. Type VII Toxin Antitoxin Systems. 
The newly categorized Type VII Toxin Antitoxin Systems have the antitoxin gene codes 
for an enzyme that spontaneously deactivates the toxin by oxidizing the cysteine amino acid into 
sulphonic, sulphenic or sulphinic acid derivative (Marimon et al., 2016) This oxidation reduction 
reaction destabilizes the toxin making its half-life significantly shorter. This constitutes a novel 
mechanism of toxin neutralization as there is no stable complex formed between the toxin and the 
antitoxin. That been said had made it recently declared as a novel class of Toxin Antitoxin Systems 
(Song & Wood, 2018a) Thus far, Marimon and their colleagues characterized the Hha/TomB TAS 
member of this class leaving it open for further research (Marimon et al., 2016) 
1.2.3. Roles of the Chromosomal Toxin Antitoxin Systems 
The chromosomal Toxin Antitoxin Systems (TAS) have wide range of molecular functions 
that translates to few, yet critical, biological functions (Harms et al., 2018a)  The driving force for 
the TASs are the functions of the toxins. The antitoxin role is regulation of the toxins’ actions. 
Although several antitoxin have numerous other roles in the global transcription regulatory 
networks of the bacterial physiology, the toxins roles are much more diverse (Makarova et al., 
2009a; Slayden, Dawson, & Cummings, 2018; Xia et al., 2019) 
1.2.3.1. Molecular Functions 
 Toxins, by definition, are enzymes that compromise cellular normal physiology. They 
perform this at every step on molecular biology central dogma and, mostly, at very low relative 
protein concentration (Harms et al., 2018a, 2017; Klein & Klein, 2016)  
Nucleases Toxins 
The majority of such are nucleases. Under this class, toxins include ribosome-dependent 
mRNA endonucleases like that of the RelE Superfamily (Christensen & Gerdes, 2003; Pedersen 
et al., 2003) Also, ribosome-independent mRNA endonucleases such as the MazF and HicA 
families (Jørgensen et al., 2009; Masuda & Inouye, 2017; Sofos, Xu, Dedic, & Brodersen, 2015; 
Yonglong Zhang et al., 2003) Also, the tRNA nucleases and rRNA nucleases are common among 
TAS families, for instance, the PilT N-terminus PIN containing toxins (Winther & Gerdes, 2011) 
Finally for the nucleases class, there are DNAses present in, for example, RalRA TAS (Guo et al., 
2014) 
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Transferases Toxins 
Aside from the nucleases, toxins could alter the post translation machinery of the bacteria; 
the toxins Death on curing (Doc) and the HipA are kinases that phosphorylates the elongation 
factor EF-Tu and glutamyl-tRNA synthetase GltX, respectively (Castro-Roa et al., 2013; Germain, 
Castro-Roa, Zenkin, & Gerdes, 2013) The tRNA targeting acetyl transferases are the main action 
of the Gcn5-related N-acetyltransferases(GNAT) (Cheverton et al., 2016; Salah Ud-Din, 
Tikhomirova, & Roujeinikova, 2016; Yeo, 2018) The FicT toxin family are AMP transferases that 
targets enzymes of DNA replication, namely, topoisomerase and gyrase (Harms et al., 2015) PezT 
toxins interferes with peptidoglycan biosynthesis through phosphorylation (Mutschler, Gebhardt, 
Shoeman, & Meinhart, 2011) Lastly, the toxin component of the DarAT TAS is a reversible ADP-
ribosyl transferases that act on DNA single strand (Jankevicius, Ariza, Ahel, & Ahel, 2016) 
Oxidoreductase Toxins  
Even though it is poorly understood, the Hok toxins are depolarizing agents that interrupts 
the ATP synthesis process at the plasmic membrane (K Gerdes, Bech, et al., 1986; Verstraeten et 
al., 2015) 
Stoichiometric and steric hindrance 
Unlike the topoisomerase inhibitor FicT discussed above, the CcdB toxin inhibits the 
topoisomerase, but through a different mechanism. It poses a steric hinderance upon physical 
interaction with the FtsZ or the MreB terminating the polymerization step and halting the DNA 
replication process with a non-enzymatic approach  (Bernard & Couturier, 1992; Masuda et al., 
2012)  
1.2.3.2. Biological Functions 
The topic of biological roles of the toxin antitoxin systems is heated subject in the scientific 
community. It can be classified into dynamic evolution and environment adaptation.   
Dynamic Evolution 
The Toxin Antitoxin Systems are known for their Post-Segregational Killing of plasmid-
lost daughter cells as discussed above. As for the TAS in the chromosome, several studies had 
proven its addiction properties for the dynamic portions of the genome; i.e. Chromosomal Mobile 
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Genetic Elements. Examples for this include stabilization of the prophage CP4So of the 
Shewanella oneidensis (J. Yao et al., 2018), the IncA/C genomic island in Salmonella spp. 
(Huguet, Gonnet, Doublet, & Cloeckaert, 2016) , SsPI-1 pathogenicity island in Streptococcus suis 
(X. Yao et al., 2015), several prophages in Bacillus subtilis (Durand, Jahn, Condon, & Brantl, 
2012), the integrative conjugative element ICEAfe1 is addicted to the genome of Acidothiobacillus 
ferroxidans (Bustamante, Tello, & Orellana, 2014), the ICE SXT is maintained through the Vibrio 
cholera genome by a TAS (Wozniak & Waldor, 2009) and, finally, a Super Integron (SI). is the 
first one to be verified that it can be diminished upon loss of the TAS found in the SI set of genes, 
which means it is indeed addicted to the chromosome (Szekeres, Dauti, Wilde, Mazel, & Rowe‐
Magnus, 2007) In spite of this, certain discrepancies and concerns on the experimental design for 
the functional assays of such TAS role (Song & Wood, 2018a)  
The addiction can be for the unit gene as a selfish element within the genome of the same 
bacteria. The TAS maintained elements can be observed along with housekeeping genes localized 
near the origin of replication. This means that in an intra-genomic conflict, as a gene, it has high 
selfishness character over other genes of the bacteria (Rankin Daniel J., Turner Leighton A., 
Heinemann Jack A., & Brown Sam P., 2012) The selfishness of the TAS should not be taken as 
being only pathogenic to the genome. In such evolution, the bacteria mostly kept the TAS 
associated with beneficial impact to the bacteria (Ramisetty & Santhosh, 2017)  
The TAS have anti-addiction functions. This means that the genome will not accept mobile 
genetic elements, plasmids or phages much like an immune system for the bacteria like the 
Restriction Modification (RM) systems and the clustered regularly interspaced short palindromic 
repeats CRISPR-Cas systems. On the other hand, the mobile genetic element, plasmid or phage 
get to choose its host. This happens by the incompatibilities of different Toxin Antitoxin Systems 
families where the cross-talk regulation favors the expression of the toxin for the uninvited MGE 
(Saavedra De Bast, Mine, & Van Melderen, 2008) 
The abortive infection system is an innate immune system for bacteria where the infected 
individual altruistically suicide for the benefit of the population. This happens through the 
activation of the toxin of the TAS when the bacteriophage enters the bacteria and before its 
replication. This makes the TAS, especially Type III and IV, potent abortive infection systems 
(Dy, Przybilski, Semeijn, Salmond, & Fineran, 2014; Dy, Richter, Salmond, & Fineran, 2014; 
Goeders et al., 2016)  
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Environment Adaptation 
Under stress conditions and extreme environment, such as therapeutic antibiotic use, the 
bacterial population can tolerate such environment by keeping certain subpopulation as dormant 
as possible leaving out any energy expenditure. This phenomenon is known as persistence. The 
Toxin Antitoxin Systems (TAS) are an integral part in this pathway. With certain concentrations 
of the toxin, the cell become dormant and quit all translational biosynthesis cellular processes 
(Ronneau & Helaine, 2019) When the environment conditions return favorable, the antitoxin is 
expressed again and regulate the toxin actions reversing back the dormant persisters to normal 
population. This phenomenon is of tremendous importance as this adaptation allows the bacteria 
to evolve resistance mechanisms; besides, clinically, bacterial eradication from the host is difficult 
(Harms, Maisonneuve, & Gerdes, 2016; Page & Peti, 2016) Moreover, the persisters population 
often become heterogenic. These bet hedging phenotypes signals the rest of the population for a 
quicker response to the stress condition (Veening, Smits, & Kuipers, 2008) As global regulators, 
the Toxin Antitoxin Systems are implicated with extensive regulations of quorum sensing and 
biofilm formation (Chan, Espinosa, & Yeo, 2016; Wang & Wood, 2011; Wen, Behiels, & 
Devreese, 2014) These roles put the Toxin Antitoxins Systems as a clinically interesting target for 
drug design of novel anti-infective therapies and key molecular system to study to better 
understand basic science of bacterial communities including that of biotechnological – industrial 
microbes. 
1.2.4. Importance of the Toxin Antitoxin Systems 
In the human oral microbiome, the toxin antitoxin systems have a lot of potential in 
translational medicine. Understanding the biology of the TAS helps in properly understanding the 
etiologies of oral and systemic diseases. On the other side, understanding the toxin antitoxin 
systems dynamics on a population level with a rich arena of the oral ecosystem is principal for 
making use of the TAS in numerous applications from high-yield industry to synthetic biological 
circuits.  
There are numerous applications for the Toxin Antitoxin Systems. Possibly, we can design 
novel antibacterial without emerged resistance to it, which is a topic, currently, under extensive 
research. However, we will focus on the biotechnological applications of the Toxin Antitoxin 
systems as there are several up-to-date reviews on the clinical or chemotherapeutic applications 
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elsewhere in the literature (Bassegoda, Ivanova, Ramon, & Tzanov, 2018; Harms, Brodersen, 
Mitarai, & Gerdes, 2018b; Khusro, Aarti, Barbabosa-Pliego, & Salem, 2018; van Geelen, Meier, 
Rehberg, & Kalscheuer, 2018; Q. E. Yang & Walsh, 2017) 
A Tool in Cloning  
DNA cloning has the problem of low frequency of the DNA insert. In addition to the 
problem of plasmid loss after several generations in the transformed cells. Therefore, Toxin 
Antitoxin systems were used as a toolbox in designing kits that enhance the cloning frequency. 
StabyCloningTM system and Gateway TM system are examples for kits that used CcdAB TA 
module for stabilizing the cloned DNA fragment insert (Stieber, Gabant, & Szpirer, 2008; 
Unterholzner, Poppenberger, & Rozhon, 2013) There are different ways to positively select the 
insert cloned. The insert could contain a toxin gene that is disrupted upon the insertion of the DNA 
fragment to be cloned. If the vector has the insert, the toxin will not be activated. Thus, positively 
selecting for the transformed hosts that have the insert (Bukowski, Rojowska, & Wladyka, 2011) 
Another strategy is to design the vector to have a fragment of the antitoxin making the antitoxin 
inactive. However, the insert is ligated with the remaining fragment of the antitoxin that, if inserted 
successfully in the correct orientation, will produce a complete active antitoxin that will rescue the 
host cells form an inducible toxin expression (Stieber et al., 2008) The above-mentioned 
GatewayTM system uses another approach. The recombination sites attB1 and attB2 are to be 
flanking around the insert to be cloned. The vector should include the recombination sites attP1 
and attP2 besides the integrase enzyme and the integration host factor. In the vector the attP1 and 
attP2 sites flanks the toxin component of the CcdAB system. Here, a powerful selection will occur 
to the vectors that underwent integrase-mediated homologous recombination; the toxin is replaced 
by the insert (Stieber et al., 2008)   
A Tool for Expression Vectors for Protein Production 
There are several major challenges for the protein production and gene expression systems. 
The plasmid is not stable and/or maintained throughout several generations of the microorganism. 
This expression vector could be lost due to its fitness cost. Other plasmids that lack the expression 
of the protein are more robust in their growth and replication than the expression vector, which 
lead them to be selected over the expression plasmid. The use of antibiotics to place a selective 
pressure on the plasmids could be an answer. However, it has several drawbacks. The product is 
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at danger of contamination with antibiotics that could have side effects on the consumers. The 
release of the antibiotic or antibiotic resistance in nature is risky. In large scale production, there 
is a problem that resistant cells could deactivate the antibiotic in the bioreactor leading to higher 
chances for competitor plasmids to outgrow the expression plasmid. Accordingly, the Toxin 
Antitoxin system could be used to avoid these drawbacks and increase the yield of protein 
production. Similar to its natural role in Post Segregationally Killing (PSK), TA systems could 
offer marvelous solution for plasmid stability (Pecota, Kim, Wu, Gerdes, & Wood, 1997) Several 
strategies from this concept are out there. The toxin gene could be engineered in the genome and 
the antitoxin on the expression vector; that way the plasmid is addicted to the host. One of the most 
successful systems is the food grade expression system developed in Bacillus subtilis in 2016 (S. 
Yang, Kang, Cao, Du, & Chen, 2016)  
Single Protein Production systems 
One of the systems to have higher yields out of an expression vector is the design of a 
Single Protein Production (SPP) system. In Escherichia coli, the toxin component of the MazEF 
TA system is an endoribonuclease enzyme that can act to interfere with the total mRNA of the 
cell. Specifically, the MazF toxin targets the degradation of the mRNA containing the sequence 
ACA. The cell growth is arrested; however, the translation machinery was still operating for four 
days after the induction of the toxin. The protein of interest to be produced is engineered to lack 
the sequence ACA (ACA-less mRNA). Upon inducing the toxin expression, all mRNA of the host 
is degraded except for the ACA-less mRNA of the protein of interest. All resources of the cell will 
be available for this single protein to be expressed in high yields. This system is proved to be 
superbly successful (Suzuki, Zhang, Liu, Woychik, & Inouye, 2005)   
A Tool to Target Cell Ablation in Plants  
For developing model systems, a cell ablation tool was developed using the Toxin 
Antitoxin system. The antitoxin is derived by a promoter that is expressed in all plant tissue except 
the only one to be ablated. On the contrary, the toxin is downstream of a promoter that is 
specifically expressed in the tissue to be ablated. This system was proven to be successful 
(Baldacci-Cresp et al., 2016)   
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Stable Killer Switch 
A synthetic genetic circuit was developed using the Toxin Antitoxin systems as a switch 
to kill the bacteria Escherichia coli in response to a certain stimulus. This killing switch is designed 
to be evolutionary stable. This tool is extremely powerful; it can be used in different applications. 
The microbial growth in mammalian gut is controlled by the temperature as a killer switch (Stirling 
et al., 2017) Another application is a killer switch that is engineered to bacteria that escaped certain 
path or to control the bacteria for containment. The unwanted bacteria are switched to be killed by 
a certain stimulus, for example cold shock causing “Cryodeath” (Boettner, 2017) This 
phenomenon hold humongous potential as the killer switch can be used for bacteria that perform 
certain therapeutic and/or theranaustics role giving it a license to kill and, then, by the killer switch 
the bacteria itself is killed, meaning the killing machines are temporally and spatially controllable.   
Inducible Cell Lysis Systems in Bio-production  
One of the problems that bio-production faces is the release of the protein expressed outside 
of the cells. Mechanical, chemical or enzymatic cell lysis techniques are commonly used to release 
the protein for further purification. Here, the researchers could engineer a cell lysis system that is 
cost-efficient, controllable, reproducible and efficacious. The regulatory system involves the Toxin 
Antitoxin system that is conditionally inducible to lyse the cells after they complete their role in 
the bio-reactors (Y. Gao, Feng, Xian, Wang, & Zhao, 2013)    
Engineering Resistance to Phage in Bioreactor Cells 
The bacteria Geobacillus thermoglucosidasius is used in biofuel production. However, the 
common problem to these bacteria is phage infection that drastically affect the fermentation 
process. The toxin csaB of the TA system is engineered to promote the resistance to the phage 
GVE3 that hinder the bacteria from biofuel production, thus, leading to higher viability in the 
bacterial population (van Zyl, Taylor, & Trindade, 2016)  
A Reporter for Identification of Quorum Sensing 
The phenomenon of Quorum Sensing (QS) in prokaryotes changed our view of the 
microorganisms. They are sociable with several communication pathways and signals intraspecies 
and interspecies. However, not all microorganisms and/or all pathways are discovered. In fact, 
there is a deep need in detecting new signal pathways in both quorum sensing and quorum 
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quenching as both are potential novel chemotherapies. Identifying the biomolecules involved in 
these pathways are made easier using a reporter system. The reporter system, here, is Escherichia 
coli that is engineered with CcdAB TA system linked to promoters that can detect the QS families 
of signals in both Gram-positive and Gram-negative bacteria, namely, acyl homoserine lactone 
and autoinducer-2 families. The reporter system was validated and were able to detect the QS of 
34 species (Weiland-Bräuer, Pinnow, & Schmitz, 2015)    
TA Systems and Bio-photonic Imaging 
Imaging of bacteria during the disease in real-time manner is important to study 
pathophysiology and etiology of infectious diseases. This is possible through luminescence optical 
imaging. The bio-luminescence technology has many benefits to illuminate the sample for real-
time optical imaging. The Toxin Antitoxin systems can play an important role in developing this 
technology. For example, the research group at University of Auckland developed a system using 
ω–ε–ζ TA system; it stabilized the plasmid containing luciferase reporter genes in Group A 
Streptococcus (GAS) strains. The bioluminescence signals were quantifiable to be analyzed in 
culture and animal disease models (Loh & Proft, 2013) 
TA in Genome Editing 
Genome editing revolutionized our approach in biotechnology. Now, no viral vectors or 
plasmids would remain in the host. The application arena is vast, starting from crop editing 
bypassing the GMO labelling regulation dilemma to advancing medical and therapeutic tools. With 
the appearance of tools like CRISPR and TALEN, genome editing became much easier process. 
However, the off-targeting remains a problematic drawback (Germini et al., 2018) 
Although the system works on Gram-positive bacteria only, the genome editing tool toxin 
counter–selectable cassette regulated by an antitoxin switch (TCCRAS) holds a very promising 
versatile tool for genetic engineering and synthetic biology. Several approaches could be done with 
this tool including, large scale deletions, in-frame deletions, point mutations, large scale insertions 
and gene knock-ins. For example, the researchers successfully engineered Lycopene biosynthesis 
pathway in Bacillus subtilis using TCCRAS claiming minimal off targets. In the TCCRAS tool, 
the Toxin Antitoxin system RelBE has been adapted to a switch with inducible promoter and the 
whole system is harbored on plasmid that is integrated in the chromosome (Wu et al., 2018) 
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1.3. Objectives 
The Toxin Antitoxin Systems have huge potentials in both the industry and on the bed side. 
However, to fully understand the TAS, we should understand them collectively on the system level 
in bacterial populations, especially those related to the dynamic human host niche with rich HGT 
events like that of the human oral microbiome. This project aims to study the distribution, 
abundance and the evolutionary ecology of the chromosomal type II toxin antitoxin systems in the 
human oral microbiome which requires hitherto predictions of putative toxin antitoxin systems in 
such microbial community.  
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2. METHODOLOGY 
2.1. Ethical Statement 
All of the human sampling in this study has been approved by the Institutional Review 
Board (IRB) of the American University of Cairo which adequately address the participating 
subjects of this study in an ethical manner.  
2.2. Microbiome Analysis 
Three samples were taken from a 26-years-old Egyptian, presumably, healthy individual 
claiming good oral hygiene. The location of the sampling was in Atlanta, United states of America 
(33.7590 N 84.3987 W). The samples were taken by gentle rubbing of a sterile cotton-headed tip 
to the left canine supragingival and subgingival dental plaque. The third sample was for the buccal 
mucosa neighboring the same canine tooth. The sample was sent to Zymo-Research® Company 
for targeted 16S rRNA sequencing.  
The ZymoBIOMICS® 96 MagBead Kit (Zymo Research, Irvine, CA) was used for total 
DNA extraction of the three samples using the company’s manual protocol.  The Quick-16S™ 
NGS Library Prep Kit (Zymo Research, Irvine, CA) was used to prepare the samples for targeted 
sequencing of the 16S ribosomal RNA gene variable regions of V3-V4 using customized primers. 
PCR reactions were conducted in real-time PCR machines to control cycles. qPCR fluorescence 
readings quantified the final PCR products and pooled them together on equal molarity basis. The 
Select-a-Size DNA Clean & Concentrator™ (Zymo Research, Irvine, CA) cleaned up the final 
pooled library. Afterwards, the pooled library was quantified with TapeStation® and Qubit®. 
Illumina® MiSeq™ was used for sequencing the final library prepared. This was done with a v3 
reagent kit (600 cycles) with >10% PhiX spike-in. 
Two methods were applied for unique amplicon sequences identification and chimera 
errored sequences; one using vsearch version 1.41.3 (Rognes, Flouri, Nichols, Quince, & Mahé, 
2016; Schloss et al., 2009) The other is using the Dada2 pipeline. (Callahan et al., 2016) Then, 
Sequence data were deposited in NCBI Genbank (Benson, Karsch-Mizrachi, Lipman, Ostell, & 
Wheeler, 2005) with assigned accession number, BioProject number and BioSample number that 
are mentioned in the results section. Taxonomic assignments were done using three databases as 
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reference, an internal script with Zymo’s own curated 16S database, GreenGene database 
(DeSantis et al., 2006) and SILVA database (Quast et al., 2013) These assignments were done 
using Uclust from Qiime version 1.9.1(Bolyen et al., 2018) and Mothur version 1.35.1 (Schloss et 
al., 2009) Composition visualization of box plots and Bray-Curtis dissimilarity heatmaps, alpha-
diversity and beta-diversity analyses were performed with Qiime v.1.9.1 (Bolyen et al., 2018) and 
plotly in R (https://www.rstudio.com/).  
2.3. Toxin – Antitoxin Systems Prediction 
2.3.1. Retrieval of Genomic Data 
From the genera found in the oral microbiome, selected species were chosen for 
downstream analysis. The genomic data were retrieved from NCBI genome database and RefSeq 
that showed sequence similarity with 16S rRNA gene as assigned from the SILVA database. The 
fifty most abundant Operational Taxonomic Units (OTUs). that are more than 97% similarity with 
the afore-mentioned SILVA database were included in downstream analysis.  
2.3.2. Pipeline for Prediction 
The database Toxin Antitoxin Database (TADB) is the principal database used in the 
primary detection of the type II toxin antitoxin systems (Xie et al., 2018b, p. 0) Using the tool 
TAfinder (http://202.120.12.133/TAfinder/), the genomic data was run through BlastP (McGinnis 
& Madden, 2004) with e-value threshold of 0.001 against TADB where the Coding Sequences 
(CDS) of each genome were blasted and results of the toxins and antitoxins were only considered 
if there are genomic interspace that ranges from being overlapped by 40 bases and up to interspace 
distance of 300 bases. Another search is done against TADB Hidden Markov Model profiles 
through HMMER (Finn, Clements, & Eddy, 2011) with e-value threshold of 0.01. 
Afterwards, the output of such processes was comprehensively analyzed by Position 
Specific Iterated Blast (PSI Blast) of minimum six iterations or upon convergence. Additionally, 
it was concurrently used with Pattern Hit Initiated Blast (PHI Blast) and Reverse PSI Blast using 
MEME, InterproScan or CD-search to detect distant similarities with highly similar domain 
architecture (Altschul, Gish, Miller, Myers, & Lipman, 1990; Altschul et al., 1997; Bailey, 
Williams, Misleh, & Li, 2006; Jones et al., 2014; Marchler-Bauer et al., 2002; Mitchell et al., 2018; 
Z. Zhang et al., 1998) 
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Homology modelling of the 3D structure of selected potential TA loci was done using 
either of I-Tasser or SWISS Model based on the TAS in question (Benkert, Biasini, & Schwede, 
2011; Bertoni, Kiefer, Biasini, Bordoli, & Schwede, 2017; Bienert et al., 2017; Guex, Peitsch, & 
Schwede, 2009; Schwede, Kopp, Guex, & Peitsch, 2003; Waterhouse et al., 2018; J. Yang & 
Zhang, 2015, 2015) Then, information was analyzed for the structural similarity with BtoxDB 
database of Toxin Antitoxin Systems structures from Protein Data Bank using flexible jFATCAT 
algorithm (Barbosa, Garrido, & Marchetto, 2015; Prlić et al., 2010; Ye & Godzik, 2003)  
TA loci that directly inferred from above pipeline were manually curated for annotation. 
For novel TAS declarations, manual curation and literature-based study of each individual 
potential TA loci along with the assembly of motifs and domains architecture, families and super 
families were done to declare them or demote them as putative novel Toxin Antitoxin Systems. 
Toxin Antitoxin genes nomenclature was avoided and only membership to TAS super-families 
and families classification was employed in this study.  
2.4. Toxin Antitoxin Systems Abundance and Diversity 
The Toxin Antitoxin Systems (TAS) abundance was calculated in different contexts. 
Abundance of the TAS in the oral microbiome, relative molecular abundance of the TAS in the 
pool of genes of the oral microbiome and heatmap of specific abundance pair-wised for TAS in 
each OTU were visualized and graphed by GraphPad Prism, R studio, and heatmapper program 
(Babicki et al., 2016; Khan, 2013; Swift, 1997) Circos is used for tabular visualization of TAS 
domains abundance in OTUs of the oral microbiome (Krzywinski et al., 2009) The diversity of the 
Toxin Antitoxin Systems is calculated by different indices. These are Berger-Parker index, 
Margalef index, Simpson indices, Shannon index and Pielou index (Berger & Parker, 1970; E. K. 
Morris et al., 2014; Shannon, 1948a; Simpson, 1949) 
2.5. Toxin Antitoxin Systems Network 
Undirected protein – protein interaction network was built for the toxin antitoxin systems 
using both CytoScape version 3.7.1 and OmicsNet using internal scripts for calculation of 
necessary centralities of degree, betweenness, eigen vector, transitivity and closeness (Kofia, 
Isserlin, Buchan, & Bader, 2015; G. Zhou & Xia, 2018, 2019)  
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2.6. Toxin Antitoxin Systems Evolutionary and Phylogenetic Analysis 
Molecular Evolutionary Genetic Analysis (MEGA) version X is the principal tool used to 
compute phylogenetic analysis of the Toxin Antitoxin Systems predicted in the Oral Microbiome 
(Kumar, Stecher, Li, Knyaz, & Tamura, 2018) The putative TAS loci were multiple-aligned using 
MUSCLE accessed from MEGA X. (Edgar, 2004) Then, a best fit model was calculated to be used 
to produce bootstrapped Maximum Likelihood phylogeny using MEGA X (Felsenstein, 1973; 
Henderson, 2005) Finally, test of molecular clocks was computed for the TAS phylogeny 
(Goldman & Whelan, 2000; Tajima, 1989; Whelan & Goldman, 2001) Molecular allometric 
analysis was done by comparing genome size with number of genes and/or number of TAS loci 
by linear regression analysis of Pearson’s correlation represented on a scatter plot with linear 
regression line visualized through GraphPad Prism tool (Swift, 1997)   
2.7. Statistics  
Detailed statistics are described in place as per the statistical tests’ results inference. The 
statistical analysis employed in this study tests the null hypothesis and considers significance in 
rejection and/or failure of rejection by p-value of maximum value 0.05, unless, otherwise 
specifically stated elsewhere in the thesis document.  
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3. RESULTS AND DISCUSSION 
This project aims to study the chromosomal type II Toxin Antitoxin Systems in the oral 
microbiome in terms of predictions, abundance, distribution, diversity, network and evolution. The 
reason for this study in the oral microbiome is because of the dynamics of this rich niche. Recently, 
studies on the association of such niche with oral and systemic pathologies are extensive and show 
insufficient understanding of the etiology (Healy & Moran, 2019; Krishnan et al., 2017) Thus, 
diving into the molecular systems might hold clear insights for the behavior of the microbiome 
related to these clinical diseases. As a primer to this approach, predictions and distribution of the 
toxin antitoxin systems in the oral microbiome is the core of this project. 
Contrast to the whole systems approach, the chromosomal type II toxin antitoxin systems 
had been studied comprehensively in isolated species. As of January 2018, the toxin antitoxin 
systems have been studied in 613 species with a total of 5634 predicted TAS, of which 144 TAS 
have been validated experimentally (Xie et al., 2018). However, there are limited studies associates 
specifically with the oral species; example of these include Aggregatibacter 
actinomycetemcomitans, Streptococcus mutans, Treponema denticola, Lactobacillus rhamnosus, 
Bacillus globigii, Streptococcus pneumoniae and Haemophilus influenzae (Ahn & Rice, 2016; 
Dufour et al., 2018; Krügel et al., 2015; Mitchell et al., 2010; Schneider, Weigel et al., 2018; 
Sijbrandij et al., 2014; Tikhomirova et al., 2018). Clearly, the toxin antitoxin systems are studied 
in isolated species leaving space for research in studying TAS roles in systems of multicellular 
organismal behavior of microbiomes. 
In environmental microbiomes, there had been few attempts to study the TAS primarily to 
understand their roles in stress response, persisters formation, quorum sensing, disseminating 
antimicrobial resistance genes and virulence determinants (Hõrak & Tamman, 2017). In the abiotic 
environment, studies on a polluted river called Zenne in Brussels, Belgium showed metagenomic 
clusters of TAS in proximity to beta-lactamase resistance gene and histidine biosynthesis operon 
(Vercammen et al., 2013). Another study was conducted on metagenome of the ground water 
where plasmodial TAS were found spanning multimetal resistance genes (Kothari et al., 2019). 
For wastewater environments, metagenomic studies on integrons revealed several hypothetical 
proteins that are implicated with toxin antitoxin systems among other stress related genes (Gatica 
et al., 2016). Most interestingly, a study was done on the microbiome of decaying wood and soil 
of a rainforest in Puerto Rico. They studied a special category of the microbial interactions in the 
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microbiome that involves the toxin antitoxin systems, secondary metabolites, fitness genes, 
quorum sensing and quorum quenching systems. These systems are main players of the complexity 
nature of the microbiome, for which they specifically termed these as the “sociomicrobiome.” The 
researchers promote studying other ecosystems based on the same concept (Santiago-Rodriguez, 
Toranzos, Bayman, Massey, & Cano, 2013).  
Aside from the sociomicrobiome, there has been recent studies on the complexity of 
microbial interactions in biotic environments. A metagenomic study on the marine sponge showed 
highly developed organismal behavior such as specialization of metabolic pathways, but universal 
unity in defense interplayed by global regulatory network of toxin antitoxins systems and 
restriction modification systems (Slaby, Hackl, Horn, Bayer, & Hentschel, 2017). The human 
microbiome projects that involves TAS analysis are few. In 2019, Danilenko research group had 
comprehensively studied the Toxin Antitoxin Systems in the gut microbiome for developing 
software called TAGMA (Klimina et al., 2019). Finally, a comprehensive study on all metagenome 
of the human microbiome project that is deposited in the ftp website for NCBI before February 
2014 was done for CRISPR -Cas systems prediction and analysis. This study collaterally predicted 
neighboring Toxin Antitoxin Systems in several body niche including the oral microbiome (Zhang, 
Doak, & Ye, 2014). As obvious, there is a lack in the research of the Toxin Antitoxin Systems in 
the Human Microbiome. 
By searching the literature, from June 2017 till April 2019, by several keywords including 
logic combinations of “Toxin”, “Antitoxin”, “Oral”, “Microbiome” and “Metagenome” in public 
databases of “PubMed” (https://www.ncbi.nlm.nih.gov/pubmed/), there is no research journal 
article that discusses the analysis of the toxin antitoxin systems in the human oral microbiome. 
Therefore, the importance of this project, which analyze the human oral microbiome of a healthy 
individual, lies in understanding roles of molecular systems of the oral microbial interactions that 
influence pathogenesis. 
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3.1. Human Oral Microbiome Analysis 
 The analysis of the targeted sequencing of the 16S rRNA gene of three samples taken from 
the biofilms of the supragingival, subgingival plaques and buccal mucosa. The samples are termed 
oral 1, oral 2 and oral 3, respectively. They are presented in terms of taxonomy composition and 
abundance (From Figure 3-1 to Figure 3-3). This Targeted Locus Study project has been deposited 
at DDBJ/EMBL/GenBank under the accession KCXV00000000. The version described in this 
thesis is the first version, KCXV01000000. The BioProject accession number is PRJNA527703 
and the BioSample accession number is SAMN11158134. The total OTUs are 89601 sequences. 
Figure 3-1 and Figure 3-2 are box plots that visualize the abundance percentage of the phyla, 
genera and species of the oral microbiome. Different colors represent different taxa. The legends 
for figure colors are omitted for redundancy and simplicity. The heat map represented in (Figure 
3-3) denote the abundance of each unique Operational Taxonomic Unit (OTU) of those used in 
the downstream analysis for TAS predictions. The Microbiome abundance table S1 is in the 
appendix section.  
 
Figure 3-1: The composition of the microbial community in the oral microbiome from three 
different samples from supragingival, subgingival plaque and buccal mucosa respectively as oral 
1, oral 2 and oral 3. The composition on the level of phyla is represented by different colors as 
represented. 
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(A)
 
(B)
 
Figure 3-2: The composition of the microbial communities in the oral microbiome from three 
different samples from supragingival, subgingival plaque and buccal mucosa respectively as oral 
1, oral 2 and oral 3. Figure (A) shows the composition on the genus level and figure (B) on the 
species level with different colors representing abundance. Refer to text for details of the 
taxonomy. 
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Figure 3-3: Heatmap for Unique Operational Taxonomic Units in three samples from the Oral Microbiome.  
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Three samples of the oral microbiome were taken from different sites in the oral 
microbiome. Although these sampling sites were not meant to be studied vis a vis comparing each 
to another, the analysis is done separately for each sample. These sampling sites are specifically 
chosen because they are of the thickest and rich biofilms in the oral microbiome compared to other 
biofilms of the hard palate, soft palate, …etc. (Bowen et al., 2018; Mark Welch, Rossetti, Rieken, 
Dewhirst, & Borisy, 2016) However, the reason of taking the samples from the canine tooth is just 
for ease of access.  
Much like the literature, the most abundant phyla here in this study for the subgingival and 
supragingival plaque is the Firmicutes (Escapa et al., 2018; Mark Welch et al., 2016) In the third 
sample of the buccal mucosa, it showed higher abundance in the Bacteroides in more or less the 
same as Firmicutes. This coincides with the more abundant phyla of the gut mucosal biofilms 
which is the Bacteroides (Barko, McMichael, Swanson, & Williams, 2018; Sweeney & Morton, 
2013) The most abundant genus in the supragingival and subgingival plaque is the Streptococcus, 
while that of the buccal mucosa is the Neisseria. It is evident from (Figure 3-2) that the buccal 
mucosa has higher richness of taxa over the other two samples. In fact, heatmap in (Figure 3-3) 
shows clustering of the gingival plaques samples together and out-grouping the buccal mucosa. 
The diversity of the three samples are observable and quantifiable by different calculations. 
The diversity within the samples is called alpha diversity. The calculations for this diversity are 
best visualized by rarefaction curves. The brilliance of these methods lies on the fact that the 
diversity potential of the samples is assessed accurately. For example, the diversity index for the 
number of assigned species is measured for a very low number of sequences. Then, a plot for 
gradually increasing number of sequences is done with measuring the diversity for each point. This 
increase in diversity, that is due to increase in the observed sequence, is a better measure than just 
assessing the richness of the assigned taxa for the total sequence because the diversity could 
increase as a function for increasing observed sequence and not for the innate diversification of 
the sample. Here, in the rarefaction curves, the innate diversification is observed after attaining 
plateau of the curve (Gotelli & Colwell, 2001) Figure 3-4 shows the rarefaction curve for the 
observed assigned taxa for the samples oral 1, oral 2 and oral 3. It shows the oral 3 (buccal mucosa) 
as the most diverse. 
38 
 
 
Figure 3-4: represents rarefaction curve based on the observed species. 
Other diversity indexes, such as the Shannon (Shannon, 1948b), accurately measures the 
alpha diversity as observed in (Figure 3-5) (E. K. Morris et al., 2014) This is because they combine 
the measure of evenness with that of the richness (number of OTUs). The buccal mucosa has the 
highest diversity (within sample) index compared to the subgingival and supragingival plaque. 
This is aligning with the literature for the case of healthy patients with good oral hygiene (Moon 
& Lee, 2016) For the subgingival and supragingival plaque the alpha diversity is lower. 
Nonetheless, the supragingival plaque (oral 1) has higher within sample diversity compared to the 
subgingival plaque (oral 2); however, this observation is slightly contradictory to several oral 
microbiome studies. Aside from the small sample size variations, this could be justified as each 
individual has slightly different microbiome fingerprint and it been not, at least yet, indicative to 
any major change in the host physiology or dysbiosis. This might be considered inter-personal 
microbiome normal dynamics (Hall et al., 2017)  
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Figure 3-5: Rarefaction curve representing Shanon Index. Upper and lower confidence intervals 
are not included in this graph.    
The beta diversity between the three samples are not of interest of this study as we are not 
comparing the samples to each other. However, Figure 3-6 is a Principle Component Analysis 
PCoA based on the ecological pairwise distance between the taxa compositions of the samples 
calculated by Bray Curtis dissimilarity matrix. The graph is mocked by other points to help 
visualize the profiles of the microbial community between samples. It is obvious from the figure 
that the three oral sample are clustered near each other in comparison with the mock points. This 
analysis is predictable; thus, differential details among the samples are out of the scope for this 
project. 
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Figure 3-6: Principle Component Analysis to visualize the beta diversity between the three oral 
samples taken from the oral microbiome. The three arrows points to the three samples (Orange, 
Green and Blue) among the mock red points that are termed “others”. 
From a system point of view, we are going to treat the oral microbiome as averaging the 
abundance and diversity from the three samples for the downstream analysis of the chromosomal 
type II toxin antitoxin systems analysis.  
3.2. Chromosomal Type II Toxin Antitoxin Systems Predictions 
The chromosomal toxin antitoxin systems are of a great interest to this study. This is 
because their exact roles are quite debatable as mentioned in the literature review section of the 
thesis. On the other hand, the plasmodial toxin antitoxin systems are well established as post 
segregational killing that addicts the plasmids to the population (Hayes, 2003) They are almost 
ubiquitous in all plasmids (Schuster & Bertram, 2013) The chromosomal abundance and diversity 
of the TAS are not properly addressed; studying their distribution patterns could give us insights 
41 
 
about their role especially in stress response and adaptation to changing environments in the buccal 
ecosystem (Shidore, Zeng, & Triplett, 2019)  
The type II toxin antitoxin systems are the most studied type of the toxin antitoxin systems; 
yet, there are a lot of ambiguity in detecting them in the chromosome. This ambiguity in detecting 
TAS genes are because of the small size of the gene. Another reason is the unusual GC content 
and codon usage of these genes in comparison with the rest of the context genome. (Makarova, 
Wolf, & Koonin, 2009b; Song & Wood, 2018b) For example, ab initio gene prediction tools, 
generic homology-based tools, phylogenetic and network functional enrichment tools are all 
lacking the sensitivity and specificity for detection of the TAS gene sequence pairs due to the 
miniature size and overlapping nature of the two protein-coding sequences of the TAS in addition 
to the different codon usage and GC content. Even tools that incorporate metabolic pathways 
predictions, subsystems technology, Hidden Markov Models and structural homology to the 
annotation pipelines, with default Open Reading Frame (ORF) calculations, misses most of the 
TAS identifications. Examples include DAVID, NCBI prokaryotic genome annotation pipeline 
and PATRIC/RAST annotation server (Aziz et al., 2008; Brettin et al., 2015; Gillespie et al., 2011; 
Haft et al., 2018; Huang, Sherman, & Lempicki, 2009a, 2009b; Tatusova et al., 2016) These 
specific examples for annotation tools expressively announced the exclusion of such genes. 
However, such tools could identify uncomprehensive minority annotations, especially plasmodial 
TAS (Makarova, Wolf, & Koonin, 2019) Conclusive discussions for such problems occur in nearly 
most of the research that aims at identifying genes that codes for bacterial immune response like, 
CRISPR and RM systems (Koonin & Makarova, 2013; Makarova et al., 2011; Makarova, Wolf, 
& Koonin, 2013; Mruk & Kobayashi, 2014) Clearly, there is a need for specific tools and pipelines 
for chromosomal TAS detections.  
There are specialized tools that are tailored to address the problem of missing ORFs. One 
tool, that is now obsolete, is called RASTA. This stands for Rapid Automated Scan for Toxins and 
Antitoxins (Sevin & Barloy-Hubler, 2007) Another tool, that “replaced” this one is called 
TAfinder. This one is currently supported and inhouse the most comprehensive database for the 
Toxin Antitoxin Systems (Xie et al., 2018a, p. 2) This tool uses specific default parameters for 
BlastP and HMMer pipelines that are tailored for detecting the TAS and they use the 
comprehensive database of TADB which minimizes the distance similarities with other genes. 
Therefore, there is a problem which is detecting novel TAS genes that are not yet in the TADB, 
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still display domain architecture and structure homology with that of the toxin and antitoxins in 
the TADB. These novel TAS are vastly derived from the existing knowledgebase of the domains 
and related proteins to the TAS genes that waits to be mined into (Makarova et al., 2009b) Thus, 
an exhaustive survey that is manually bio-curated is required to expand the putative TAS database 
and unleash trends in their distribution in the human oral microbiome.  
The genomic data retrieved for the analysis are not the full metagenome in the oral 
microbiome. OTUs that assigned to species that share 97% similarity with the 16S rRNA are only 
included to decrease inaccurate data as the genomic sequence is obtained from NCBI RefSeq 
database and not from the direct genomes of the samples (Haft et al., 2018) Whenever there is 
unassembled genomic sequence, the downstream analysis is applied on each contig of the project. 
To avoid duplicate detections of TAS from the contigs that are possibly overlapping, manually 
screened TAS genes of exact sequences are removed from contigs of the same taxa. As there are 
89601 OTUs, there are some that are extremely scarce and minimally abundant in the oral 
microbiome; they are omitted from TAS analysis for the unlikelihood of changing the abundance 
of TAS genes. The OTUs used in the analysis are presented in (Table 3-1) and their abundance is 
visualized in (Figure 3-3) as a clustered heatmap. 
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Table 3-1 The taxa that are involved in the down-stream analysis of the Toxin Antitoxin Systems 
UTO Accession or Assembly Number 
Capnocytophaga leadbetteri CP022384.1 
Lautropia mirabilis LR134378.1 
Rothia dentocariosa CP002280.1 
Haemophilus influenzae LS483480.1 
Actinomyces oris CP014232.1 
Aggregatibacter segnis LS483443.1 
Capnocytophaga ochracea CP001632.1 
Fusobacterium canifelinum NZ_RQYY00000000.1 
Neisseria flavescens LAEI00000000.1 
Corynebacterium matruchotii ACEB00000000.1 
Prevotella intermedia CP030094.1 
Gemella morbillorum LS483440.1 
Kingella denitrificans AEWV00000000.1 
Fusobacterium nucleatum AE009951.2 
Fusobacterium periodonticum CP028108.1 
Campylobacter showae UWOJ00000000.1 
Rothia aeria AP017895.1 
Streptococcus sanguinis LS483346.1 
Gemella sanguinis PNGT00000000.1 
Veillonella atypica CP020566.1 
Streptococcus gordonii LS483375.1 
Streptococcus mutans LS483349.1 
Porphyromonas catoniae AMEQ00000000.1 
Neisseria elongata CP031255.1 
Aggregatibacter aphrophilus LS483485.1 
Alloprevotella rava ACZK00000000.1 
Veillonella parvula CP019721.1 
Streptococcus salivarius CP013216.1 
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UTO Accession or Assembly Number 
Granulicatella elegans NZ_KI391971.1 
Haemophilus parainfluenzae FQ312002.1 
Granulicatella adiacens NZ_ACKZ00000000.1 
Actinobacillus minor ACQL01 
Haemophilus haemolyticus LS483458.1 
Neisseria mucosa CP028150.1 
Streptococcus mitis NC_013853.1 
 
The chromosomal type II Toxin Antitoxin Systems predicted are classified according to 
the Type II Toxin Antitoxin Systems super-families and families classification described and 
referenced before in (Table 1-1). If the putative novel TAS do not fall into the classification in 
(Table 1-1), the domain-based classification is used as described in (Table 1-2). Although 
commonly in the literature, the putative novel TAS are assigned to be named, the nomenclature of 
the novel TAS in this project are avoided due to the recency of the detections and the common 
nebulous nature of the nomenclature as proposed by experts in the biology of the toxin antitoxin 
systems (Song & Wood, 2018b) In general, the putative predictions of the toxin antitoxin systems 
are considered novel in the scientific community; however, the computational detections of the 
TAS are not bona fide due to the lack of experimental validation and in vivo functional assay.  
The chromosomal type II toxin antitoxin systems in the oral microbiome are 278 gene 
sequences (i.e. 139 pair of TAS) that are predicted by the pipeline described in the methods. They 
are denoted in (Table 3-2). This includes manual review of the InterPro domains of each sequence, 
Gene Ontologies GO predictions, PSI Blast hits after convergence and of minimum 6 iterations, 
structural homology in abstruse cases. The family classification serves as gene-like style of 
declaring novel genes. For example, all predicted genes that have the RelB annotation are declared 
as novel RelB-like gene. In case the classification deems a domain, the declaration of the gene will 
be as domain-containing gene. For example, all predicted genes with HTH annotation are declared 
as novel HTH-domain-containing gene. Genes that are annotated in the RefSeq genome 
differently, yet showed homology throughout all stages of the pipeline, are kept as TAS genes with 
the original domain declaration. Some of the taxa has no TAS predicted; they are not tabulated in 
(Table 3-2).   
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Table 3-2: The predicted chromosomal type II toxin antitoxin systems in the oral microbiome. 
Organism TA no. T/A Locus Tag Location Manually 
Curated 
Gene 
Class 
Capnocytophaga 
leadbetteri 
TA_no. T/A Locus_tag Location  
TA_1 T CGC53_RS02185 470181..470486 MNT 
0 AT CGC53_RS02180 469856..470191 HEPN 
TA_2 T CGC53_RS03910 910662..911189 START 
0 AT CGC53_RS03905 909922..910602 HTH 
TA_3 T CGC53_RS04105 952696..952992 YoeB 
0 AT CGC53_RS04100 952451..952708 RHH 
TA_4 T CGC53_RS10070 2256679..2257134 VapC 
0 AT CGC53_RS10065 2256471..2256698 RelB 
Rothia 
dentocariosa 
TA_no. T/A Locus_tag Location  
TA_1 T HMPREF0733_10180 201492..201863 VapC 
0 AT HMPREF0733_10181 201860..202057 VapB 
TA_2 T HMPREF0733_10355 377568..378707 GNAT 
0 AT HMPREF0733_10354 376739..377443 HTH 
TA_3 T HMPREF0733_10590 644678..645097 VapC 
0 AT HMPREF0733_10591 645101..645406 Phd 
TA_4 T HMPREF0733_10761 816485..816787 MNT 
0 AT HMPREF0733_10760 816135..816488 HEPN 
TA_5 T HMPREF0733_11193 1280854..1282620 GNAT 
0 AT HMPREF0733_11192 1280138..1280851 AcrR 
TA_6 T HMPREF0733_11254 1364766..1365056 MNT 
0 AT HMPREF0733_11255 1365056..1365391 HEPN 
TA_7 T HMPREF0733_11511 1660539..1661009 HTH 
0 AT HMPREF0733_11512 1661006..1661326 HTH 
TA_8 T HMPREF0733_11698 1882625..1882885 YoeB 
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Organism TA no. T/A Locus Tag Location Manually 
Curated 
Gene 
Class 
0 AT HMPREF0733_11697 1882368..1882622 Phd 
Haemophilus 
influenzae 
TA_no. T/A Locus_tag Location  
TA_1 T NCTC13377_00047 48268..48666 VapC 
0 AT NCTC13377_00046 48035..48268 MazE 
TA_2 T NCTC13377_00076 76885..77175 RelE 
0 AT NCTC13377_00075 76641..76895 Phd 
TA_3 T NCTC13377_00298 300005..300313 RelE 
0 AT NCTC13377_00299 300313..300609 RelB 
TA_4 T NCTC13377_00347 349919..350239 HipA 
0 AT NCTC13377_00346 349623..349931 HTH 
TA_5 T NCTC13377_00352 358344..358703 RelE 
0 AT NCTC13377_00353 358696..358992 HTH 
TA_6 T NCTC13377_01012 997694..998038 MNT 
0 AT NCTC13377_01011 997261..997692 HEPN 
TA_7 T NCTC13377_01294 1293131..1293838 HipA 
0 AT NCTC13377_01295 1293938..1294603 HTH 
TA_8 T NCTC13377_01416 1396539..1397246 HipA 
0 AT NCTC13377_01417 1397346..1398011 HTH 
TA_9 T NCTC13377_01430 1403404..1403709 HigB 
0 AT NCTC13377_01429 1403114..1403407 HigA 
TA_10 T NCTC13377_01437 1406854..1407105 RelE 
0 AT NCTC13377_01436 1406523..1406870 HTH 
TA_11 T NCTC13377_01632 1614045..1614350 RelE 
0 AT NCTC13377_01631 1613711..1614034 HTH 
Actinomyces 
oris 
TA_no. T/A Locus_tag Location  
TA_1 T AXE84_01550 344964..345341 Fido 
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Organism TA no. T/A Locus Tag Location Manually 
Curated 
Gene 
Class 
0 AT AXE84_01545 344750..344953 RelB 
TA_2 T AXE84_02440 545051..545683 GNAT 
0 AT AXE84_02445 545810..546946 LsrR 
TA_3 T AXE84_02825 658137..658391 YoeB 
0 AT AXE84_02830 658391..658642 Phd 
TA_4 T AXE84_02845 661089..662333 HipA 
0 AT AXE84_02850 662330..662617 HTH 
TA_5 T AXE84_03195 747284..747661 VapC 
0 AT AXE84_03190 747090..747287 VapB 
TA_6 T AXE84_03905 913152..913553 VapC 
0 AT AXE84_03900 912928..913155 CcdA 
TA_7 T AXE84_03930 917777..918169 VapC 
0 AT AXE84_03935 918166..918387 VapB 
TA_8 T AXE84_04220 991997..992584 VapC 
0 AT AXE84_04225 992588..993073 MerR 
TA_9 T AXE84_04425 1037940..1038410 MNT 
0 AT AXE84_04420 1037554..1037943 HEPN 
TA_10 T AXE84_06645 1623445..1623798 RelE 
0 AT AXE84_06640 1623125..1623448 HTH 
TA_11 T AXE84_06935 1712733..1713014 RelE 
0 AT AXE84_06940 1713001..1713312 HTH 
TA_12 T AXE84_06970 1718075..1719739 GNAT 
0 AT AXE84_06965 1717239..1717979 AcrR 
TA_13 T AXE84_08665 2160245..2160514 YoeB 
0 AT AXE84_08660 2160009..2160251 Phd 
TA_14 T AXE84_09955 2478807..2479232 START 
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Organism TA no. T/A Locus Tag Location Manually 
Curated 
Gene 
Class 
0 AT AXE84_09960 2479229..2479789 MarR 
TA_15 T AXE84_11560 2864573..2866099 GNAT 
0 AT AXE84_11555 2864007..2864576 AcrR 
TA_16 T AXE84_11985 2963479..2963826 MazF 
0 AT AXE84_11990 2963813..2964052 RelB 
Aggregatibacter 
segnis 
TA_no. T/A Locus_tag Location  
TA_1 T NCTC10977_00366 368843..369205 RelE 
0 AT NCTC10977_00367 369202..369579 HTH 
TA_2 T NCTC10977_00853 824328..825641 MNT 
0 AT NCTC10977_00852 823368..824225 ParD 
TA_3 T NCTC10977_01792 1838998..1840278 HipA 
0 AT NCTC10977_01791 1838720..1838998 HTH 
Capnocytophaga 
ochracea 
TA_no. T/A Locus_tag Location  
TA_1 T Coch_0735 889703..889999 HigB 
0 AT Coch_0736 890004..890237 HTH 
TA_2 T Coch_0780 939775..940101 Fido 
0 AT Coch_0779 939063..939773 Phd 
TA_3 T Coch_0815 978517..978822 RelE 
0 AT Coch_0816 978825..979049 RelB 
TA_4 T Coch_0841 1003635..1003955 RelE 
0 AT Coch_0840 1003367..1003642 RHH 
TA_5 T Coch_0997 1170527..1170850 RelE 
0 AT Coch_0998 1170843..1171100 RelB 
TA_6 T Coch_1196 1403828..1404136 RelE 
0 AT Coch_1197 1404140..1404382 RelB 
TA_7 T Coch_1229 1435589..1436116 START 
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Organism TA no. T/A Locus Tag Location Manually 
Curated 
Gene 
Class 
0 AT Coch_1228 1434881..1435531 HxlR 
Gemella 
morbillorum 
TA_no. T/A Locus_tag Location  
TA_1 T NCTC11323_00623 628213..628653 ImmA/IrrE 
0 AT NCTC11323_00624 628643..629044 HTH 
Fusobacterium 
nucleatum 
TA_no. T/A Locus_tag Location  
TA_1 T FN1664 162255..162590 RelE 
0 AT FN1665 162655..162954 HTH 
TA_2 T FN1998 500269..500451 HipA 
0 AT FN1997 499898..500218 HTH 
TA_3 T FN2046 551001..551450 GNAT 
0 AT FN2045 550464..550892 PerR 
TA_4 T FN2066 576417..576833 ImmA/IrrE 
0 AT FN2065 575990..576457 HTH 
TA_5 T FN0056 692832..693311 GNAT 
0 AT FN0055 692298..692804 GNAT 
TA_6 T FN0211 837364..837630 RelE 
0 AT FN0210 837138..837356 RelB 
TA_7 T FN0497 1141273..1141545 RelE 
0 AT FN0496 1141050..1141271 RelB 
TA_8 T FN1100 1744317..1744583 RelE 
0 AT FN1099 1744105..1744332 RelB 
TA_9 T FN1294 1952607..1953158 GNAT 
0 AT FN1295 1953248..1953655 GNAT 
Fusobacterium 
periodonticum 
TA_no. T/A Locus_tag Location  
TA_1 T C4N17_08000 1625268..1625546 YoeB 
0 AT C4N17_08005 1625540..1625779 Phd 
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Organism TA no. T/A Locus Tag Location Manually 
Curated 
Gene 
Class 
TA_2 T C4N17_09110 1824443..1824727 RelE 
0 AT C4N17_09115 1824714..1824953 RelB 
TA_3 T C4N17_09580 1921236..1921721 GNAT 
0 AT C4N17_09585 1921750..1922253 GNAT 
TA_4 T C4N17_09585 1921750..1922253 GNAT 
0 AT C4N17_09595 1922516..1922770 YefM 
TA_5 T C4N17_09590 1922263..1922523 YoeB 
0 AT C4N17_09595 1922516..1922770 Phd 
TA_6 T C4N17_10050 2023458..2023649 HicA 
0 AT C4N17_10045 2022996..2023421 HicB 
TA_7 T C4N17_10615 2118410..2119150 ImmA/IrrE 
0 AT C4N17_10610 2118037..2118423 HTH 
TA_8 T C4N17_10875 2153007..2153279 RelE 
0 AT C4N17_10880 2153281..2153544 RelB 
TA_9 T C4N17_11255 2235387..2236526 HipA 
0 AT C4N17_11250 2234505..2235152 AcrR 
TA_10 T C4N17_11255 2235387..2236526 HipA 
0 AT C4N17_11260 2236513..2236833 HTH 
TA_11 T C4N17_12205 2431810..2431992 HicA 
0 AT C4N17_12210 2432030..2432428 HicB 
TA_12 T C4N17_12260 2440858..2441268 ImmA/IrrE 
0 AT C4N17_12265 2441228..2441695 HTH 
Rothia aeria TA_no. T/A Locus_tag Location  
TA_1 T RA11412_0178 154222..154647 VapC 
0 AT RA11412_0179 154651..154956 Phd 
TA_2 T RA11412_0821 741232..742998 GNAT 
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Organism TA no. T/A Locus Tag Location Manually 
Curated 
Gene 
Class 
0 AT RA11412_0820 740558..741229 AcrR 
TA_3 T RA11412_1191 1091799..1092269 HTH 
0 AT RA11412_1192 1092266..1092721 HTH 
TA_4 T RA11412_2432 2261884..2262381 GNAT 
0 AT RA11412_2431 2261591..2261884 RHH 
TA_5 T RA11412_2432 2261884..2262381 GNAT 
0 AT RA11412_2433 2262592..2263131 HTH 
TA_6 T RA11412_2436 2264486..2264653 VapC 
0 AT RA11412_2437 2264851..2265048 VapB 
Streptococcus 
sanguinis 
TA_no. T/A Locus_tag Location  
TA_1 T NCTC11085_00324 309578..309856 RelE 
0 AT NCTC11085_00323 309322..309585 RelB 
TA_2 T NCTC11085_00917 948027..948443 GNAT 
0 AT NCTC11085_00918 948617..949228 AcrR 
TA_3 T NCTC11085_01051 1097626..1098483 GNAT 
0 AT NCTC11085_01052 1098603..1099505 LysR 
TA_4 T NCTC11085_01635 1689503..1690072 GNAT 
0 AT NCTC11085_01633 1688763..1689299 HTH 
TA_5 T NCTC11085_02225 2284014..2284886 ImmA/IrrE 
0 AT NCTC11085_02226 2284886..2285248 HTH 
Veillonella 
atypica 
TA_no. T/A Locus_tag Location  
TA_1 T B7L28_00880 227561..227965 VapC 
0 AT B7L28_00875 227301..227564 Phd 
TA_2 T B7L28_00985 253813..255006 GNAT 
0 AT B7L28_00990 255064..255951 LysR 
TA_3 T B7L28_01445 340243..340506 RelE 
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Organism TA no. T/A Locus Tag Location Manually 
Curated 
Gene 
Class 
0 AT B7L28_01440 340015..340239 RelB 
TA_4 T B7L28_02060 465243..465509 RelE 
0 AT B7L28_02055 465032..465253 RelB 
TA_5 T B7L28_09065 1992530..1992907 HicA 
0 AT B7L28_09060 1992342..1992518 HicB 
TA_6 T B7L28_09085 1997335..1997610 RelE 
0 AT B7L28_09080 1997064..1997345 RelB 
TA_7 T B7L28_09285 2039161..2040165 Fido 
0 AT B7L28_09290 2040218..2041081 HTH 
Streptococcus 
gordonii 
TA_no. T/A Locus_tag Location  
TA_1 T NCTC3165_00371 383729..384496 PezT 
0 AT NCTC3165_00370 383253..383729 HTH 
TA_2 T NCTC3165_00373 385018..385389 Fido 
0 AT NCTC3165_00372 384764..385021 Phd 
TA_3 T NCTC3165_01298 1313648..1314064 GNAT 
0 AT NCTC3165_01297 1312863..1313474 AcrR 
TA_4 T NCTC3165_01704 1732532..1733392 ImmA/IrrE 
0 AT NCTC3165_01703 1731839..1732522 HTH 
Streptococcus 
mutans 
TA_no. T/A Locus_tag Location  
TA_1 T NCTC10449_00169 173400..173732 MazF 
0 AT NCTC10449_00170 173719..174024 RelB 
TA_2 T NCTC10449_00182 183970..184224 YoeB 
0 AT NCTC10449_00183 184217..184483 YefM 
TA_3 T NCTC10449_00189 187863..188072 RelE 
0 AT NCTC10449_00190 188142..188414 RelB 
TA_4 T NCTC10449_00193 190470..191264 ImmA/IrrE 
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Organism TA no. T/A Locus Tag Location Manually 
Curated 
Gene 
Class 
0 AT NCTC10449_00192 190044..190406 HTH 
TA_5 T NCTC10449_00202 200685..201017 MazF 
0 AT NCTC10449_00201 200446..200691 MazE 
TA_6 T NCTC10449_00413 401966..402157 VapC 
0 AT NCTC10449_00412 401677..401982 MazE 
TA_7 T NCTC10449_00760 741130..741321 HicA 
0 AT NCTC10449_00761 741339..741716 HicB 
Neisseria 
elongata 
TA_no. T/A Locus_tag Location  
TA_1 T DV445_RS02635 524666..525214 GNAT 
0 AT DV445_RS02640 525321..525806 HTH 
TA_2 T DV445_RS05995 1188449..1189306 Bro 
0 AT DV445_RS06000 1189372..1190073 HTH 
TA_3 T DV445_RS12620 2480707..2481126 VapC 
0 AT DV445_RS12615 2480471..2480710 RHH 
TA_4 T DV445_RS12655 2491470..2491742 RelE 
0 AT DV445_RS12660 2491732..2491923 RHH 
Aggregatibacter 
aphrophilus 
TA_no. T/A Locus_tag Location  
TA_1 T NCTC11096_01165 1141294..1142574 HipA 
0 AT NCTC11096_01166 1142574..1142852 HTH 
TA_2 T NCTC11096_02169 2251436..2252749 MNT 
0 AT NCTC11096_02170 2252853..2253710 ParD 
Streptococcus 
salivarius 
TA_no. T/A Locus_tag Location  
TA_1 T HSISS4_00658 705771..706136 HigB 
0 AT HSISS4_00659 706126..706419 HigA 
TA_2 T HSISS4_00840 910234..911448 FmhB 
0 AT HSISS4_00841 911450..912259 HTH 
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Organism TA no. T/A Locus Tag Location Manually 
Curated 
Gene 
Class 
TA_3 T HSISS4_01146 1242750..1243268 GNAT 
0 AT HSISS4_01147 1243285..1244328 HTH 
TA_4 T HSISS4_01298 1438024..1439409 GNAT 
0 AT HSISS4_01299 1439435..1439845 MarR 
TA_5 T HSISS4_01524 1722127..1722381 YoeB 
0 AT HSISS4_01525 1722385..1722639 Phd 
Granulicatella 
elegans 
TA_no. T/A Locus_tag Location  
TA_1 T ORF1_138 164191..165234 Fido 
0 AT ORF1_139 165451..166302 HTH 
TA_2 T ORF1_182 211296..211862 GNAT 
0 AT ORF1_183 211872..212714 AraC 
TA_3 T ORF1_377 431367..431636 GNAT 
0 AT ORF1_376 430909..431334 Rrf2 
TA_4 T ORF1_630 693298..693477 HicA 
0 AT ORF1_631 693514..693969 HicB 
TA_5 T ORF1_835 907257..907529 RelE 
0 AT ORF1_834 906979..907254 RelB 
TA_6 T ORF1_854 919944..920765 Fido 
0 AT ORF1_853 919487..919753 HTH 
TA_7 T ORF1_928 998474..998653 HicA 
0 AT ORF1_927 997982..998437 HicB 
TA_8 T ORF1_1375 1460943..1461380 GNAT 
0 AT ORF1_1374 1460493..1460750 Fido 
TA_9 T ORF1_1491 1589708..1589899 HicA 
0 AT ORF1_1490 1589299..1589676 HicB 
TA_no. T/A Locus_tag Location  
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Organism TA no. T/A Locus Tag Location Manually 
Curated 
Gene 
Class 
Haemophilus 
parainfluenzae 
TA_1 T PARA_11550 1159230..1159496 RelE 
0 AT PARA_11560 1159480..1159824 RelB 
Actinobacillus 
minor 
TA_no. T/A Locus_tag Location  
TA_1 T AM305_00230 39922..40356 VapC 
0 AT AM305_00225 39686..39925 MazE 
Haemophilus 
haemolyticus 
TA_no. T/A Locus_tag Location  
TA_1 T NCTC10839_00505 499226..499486 HipA 
0 AT NCTC10839_00504 498930..499238 HTH 
TA_2 T NCTC10839_01017 1007834..1008127 MNT 
0 AT NCTC10839_01018 1008111..1008530 HEPN 
TA_3 T NCTC10839_01455 1463601..1463855 HicA 
0 AT NCTC10839_01454 1463105..1463587 HicB 
TA_4 T NCTC10839_01455 1463601..1463855 HicA 
0 AT NCTC10839_01456 1463929..1464594 HTH 
TA_5 T NCTC10839_01587 1597372..1598652 HipA 
0 AT NCTC10839_01586 1597094..1597372 HTH 
TA_6 T NCTC10839_01662 1690384..1690746 MazF 
0 AT NCTC10839_01661 1690121..1690390 MazE 
Neisseria 
mucosa 
TA_no. T/A Locus_tag Location  
TA_1 T NM96_RS06400 1295082..1295564 START 
0 AT NM96_RS06405 1295628..1296032 HTH 
TA_2 T NM96_RS10690 2119236..2119961 Aat 
0 AT NM96_RS10695 2120154..2120651 Fur 
Streptococcus 
mitis 
TA_no. T/A Locus_tag Location  
TA_1 T smi_0100 106784..107131 RelE 
0 AT smi_0099 106507..106794 RelB 
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Organism TA no. T/A Locus Tag Location Manually 
Curated 
Gene 
Class 
TA_2 T smi_0438 414401..414754 MazF 
0 AT smi_0439 414738..414953 MazE 
TA_3 T smi_0611 553127..553477 RelE 
0 AT smi_0610 552850..553137 RelB 
TA_4 T smi_0698 647243..647530 RelE 
0 AT smi_0697 646896..647201 RelB 
TA_5 T smi_1101 1089095..1089865 PezT 
0 AT smi_1102 1089865..1090341 HTH 
TA_6 T smi_1200 1192110..1192673 GNAT 
0 AT smi_1199 1191656..1192144 GNAT 
TA_7 T smi_1262 1265315..1265629 MNT 
0 AT smi_1261 1264960..1265334 HEPN 
TA_8 T smi_1262 1265315..1265629 MNT 
0 AT smi_1263 1265676..1265936 RelB 
TA_9 T smi_1273 1270051..1270410 RelE 
0 AT smi_1272 1269690..1270061 RelB 
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The distribution of the type II toxin antitoxin systems on the chromosomes of the genome 
of the oral microbiome is segregated and shows non-uniform distribution as shown from Figure 
3-7 till Figure 3-29. This distribution could imply that the TAS genes are displaying a specific 
function and not randomly occurred. One reason could be that several TAS shows proximity to the 
Origin of Replication which accentuates its selfishness character in the intra-genome (Melderen & 
Bast, 2009; Ramisetty & Santhosh, 2017) The intragenomic existence of the Toxin Antitoxin 
module is not necessary a conflict. The inclusiveness of the gene does not contradict fitness of the 
bacterial host (Gardner & Úbeda, 2017; McLaughlin & Malik, 2017; Rankin Daniel J. et al., 2012) 
The TA gene promotes maintenance of fitness factors, virulence and resistance for xenobiotics and 
phages. Thus, the TAS evolution is not best described as having Red Queen evolutionary dynamics 
where the co-evolution of selfish entities is only attributed to attack or defend the host in an arm-
race manner (McLaughlin & Malik, 2017) It is thought that TAS are skewing to the Black Queen 
evolutionary dynamics as they provide fitness characters with reduced fitness cost as they persist 
near the origin of replication of the bacterial chromosome. Although this require further 
investigations, this proximity to origin of replication ensures the quality expression of the fitness 
genes in demand that could be released to the surrounding population. On the other hand, the 
bacterium can be dependent on costly fitness genes present in the ecosystem but not invited by the 
antiaddiction role of the TAS modules. This leakiness and adaptive dependency are the main pillars 
of the Black Queen Hypothesis (Cairns et al., 2018; Goormaghtigh et al., 2018; Kang, Kim, Jin, & 
Lee, 2018; J. J. Morris, 2015; J. J. Morris, Lenski, & Zinser, 2012) 
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Figure 3-7: Cartoon to visualize intragenomic distances between toxin antitoxin systems in 
Capnocytophaga leadbetteri bacteria in the oral microbiome. 
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Figure 3-8: Cartoon to visualize intragenomic distances between toxin antitoxin systems in Rothia 
dentocariosa bacteria in the oral microbiome. 
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Figure 3-9: Cartoon to visualize intragenomic distances between toxin antitoxin systems in 
Haemophilus influenzae bacteria in the oral microbiome. 
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Figure 3-10: Cartoon to visualize intragenomic distances between toxin antitoxin systems in 
Actinomyces oris bacteria in the oral microbiome. 
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Figure 3-11 Cartoon to visualize intragenomic distances between toxin antitoxin systems in 
Aggregatibacter segnis bacteria in the oral microbiome. 
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Figure 3-12 Cartoon to visualize intragenomic distances between toxin antitoxin systems in 
Capnocytophaga ochracea bacteria in the oral microbiome. 
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Figure 3-13: Cartoon to visualize intragenomic distances between toxin antitoxin systems in 
Gemella morbillorum bacteria in the oral microbiome. 
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Figure 3-14: Cartoon to visualize intragenomic distances between toxin antitoxin systems in 
Fusobacterium nucleatum bacteria in the oral microbiome. 
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Figure 3-15: Cartoon to visualize intragenomic distances between toxin antitoxin systems in 
Fusobacterium periodonticum bacteria in the oral microbiome. 
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Figure 3-16: Cartoon to visualize intragenomic distances between toxin antitoxin systems in 
Rothia aeria bacteria in the oral microbiome. 
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Figure 3-17: Cartoon to visualize intragenomic distances between toxin antitoxin systems in 
Streptococcus sanguinis bacteria in the oral microbiome. 
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Figure 3-18: Cartoon to visualize intragenomic distances between toxin antitoxin systems in 
Veillonella atypica bacteria in the oral microbiome. 
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Figure 3-19: Cartoon to visualize intragenomic distances between toxin antitoxin systems in 
Streptococcus gordonii bacteria in the oral microbiome. 
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Figure 3-20: Cartoon to visualize intragenomic distances between toxin antitoxin systems in 
Streptococcus mutans bacteria in the oral microbiome. 
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Figure 3-21: Cartoon to visualize intragenomic distances between toxin antitoxin systems in 
Neisseria elongata bacteria in the oral microbiome. 
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Figure 3-22: Cartoon to visualize intragenomic distances between toxin antitoxin systems in 
Aggregatibacter aphrophilus bacteria in the oral microbiome. 
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Figure 3-23: Cartoon to visualize intragenomic distances between toxin antitoxin systems in 
Streptococcus salivarius bacteria in the oral microbiome. 
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Figure 3-24: Cartoon to visualize intragenomic distances between toxin antitoxin systems in 
Granulicatella elegans bacteria in the oral microbiome. 
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Figure 3-25: Cartoon to visualize intragenomic distances between toxin antitoxin systems in 
Haemophilus parainfluenzae bacteria in the oral microbiome. 
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Figure 3-26 Cartoon to visualize intragenomic distances between toxin antitoxin systems in 
Actinobacillus minor bacteria in the oral microbiome. 
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Figure 3-27: Cartoon to visualize intragenomic distances between toxin antitoxin systems in 
Haemophilus haemolyticus bacteria in the oral microbiome. 
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Figure 3-28: Cartoon to visualize intragenomic distances between toxin antitoxin systems in 
Neisseria mucosa bacteria in the oral microbiome. 
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Figure 3-29: Cartoon to visualize intragenomic distances between toxin antitoxin systems in 
Streptococcus mitis bacteria in the oral microbiome. 
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3.3. Toxin Antitoxin Systems Diversity, Abundance and Interaction Network 
The abundance of the chromosomal type II toxin antitoxin systems is important to study. 
(Harms, Brodersen, Mitarai, & Gerdes, 2018c) Their unique character of altruistic selfishness has 
impact on the TAS distribution and abundance. (Melderen & Bast, 2009; Ramisetty & Santhosh, 
2017) These become imperative as the TAS alters the plasticity of the genome and would affect it 
depending on the host environment and immune response. The abundance of the taxa used from 
the oral microbiome for the toxin antitoxin systems analysis is visualized from Figure 3-30 to 
Figure 3-33. 
 
Figure 3-30: describe the abundance of the OTUs used for the Toxin Antitoxin Systems analysis 
from Sample 1. The total of the abundance of the taxa in this figure represents 81.854% of the total 
microbiome in sample 1. 
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Figure 3-31: describe the abundance of the OTUs used for the Toxin Antitoxin Systems analysis 
from Sample 2. The total of the abundance of the taxa in this figure represents 89.7507% of the 
total microbiome in sample 2. 
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Figure 3-32: describe the abundance of the OTUs used for the Toxin Antitoxin Systems analysis 
from Sample 3. The total of the abundance of the taxa in this figure represents 61.1886% of the 
total microbiome in sample 3. 
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Figure 3-33: describe the abundance of the OTUs used for the Toxin Antitoxin Systems analysis. 
The total of the abundance of the taxa in this figure represents 77.5978% of the total microbiome.  
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To calculate the abundance of the TAS in the oral microbiome, it has to be corrected for 
the abundance of the taxa in the microbiome. This is calculated by multiplying the TAS proportion 
by the OTUs abundance in the oral microbiome samples as shown in Table 3-3 and graphed in 
figures from Figure 3-37 to Figure 3-40. Another abundance study for the TAS genes is to account 
for the genome size and number of coding sequences (CDS) per taxa. This molecular abundance 
study treats the TAS as a molecular system as a unit of interest. This calculation has been applied, 
previously in many research studies, for prophages abundance calculations as molecular entity as 
compared to the context of the coding genes they are infecting (Nadeem & Wahl, 2017). These 
data are tabulated and visualized in Table 3-4 and from Figure 3-41 till Figure 3-44. 
The frequency of the chromosomal type II Toxin Antitoxin Systems in the human oral 
microbiome is graphed from Figure 3-34 to Figure 3-36. It shows the highest frequency to the 
HTH-domain containing genes followed by RelE-like toxins. The RelE toxins are the most 
frequent type II TAS in the chromosomes in the database TADB (Xie et al., 2018a) However, the 
highly abundant HTH-domain containing proteins we observed in this project could have this 
higher frequency because they are a collection of different proteins that cannot be segmented 
through the domain and/or structural analysis applied.  
A heatmap that is constructed based on the pairwise distance between frequencies of each 
Toxin Antitoxin family predicted in each Operational Taxonomic Unit of the taxa used in the 
analysis from the human oral microbiome (Figure 3-45). Another interesting tool in visualization 
of the toxin antitoxin systems frequencies in the oral microbiome is the Circos visualization tool 
(Figure 3-46). A directed Protein-Protein Interaction Network is constructed by CytoScape based 
on the degree centrality of the Toxin Antitoxin Systems interactions (Figure 3-47). The edges 
thickness corresponds to the frequencies of the interaction. The closeness and degree centralities 
for this network are charted in Table 3-5. The molecular diversity of the type II toxin antitoxin 
systems predicted from the oral microbiome is recorded in Table 3-6.  
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Table 3-3: denotes the count and corrected abundance of the Toxin Antitoxin Systems as described in the text. 
Operational 
Taxonomic Unit 
Accession or 
Assembly Number 
TAS 
Count 
TAS % 
Corrected 
Abundance 
of TAS in 
Oral 1 
Corrected 
Abundance 
of TAS in 
Oral 2 
Corrected 
Abundance 
of TAS in 
Oral 3 
Capnocytophaga 
leadbetteri 
CP022384.1 4 2.877697842 0.000215926 0 0.000145064 
Lautropia 
mirabilis 
LR134378.1 0 0 0 0 0 
Rothia 
dentocariosa 
CP002280.1 8 5.755395683 0.000320858 0.000513028 0.000108798 
Haemophilus 
influenzae 
LS483480.1 11 7.913669065 3.8475E-05 0.001426798 0.000359967 
Actinomyces oris CP014232.1 16 11.51079137 0.000854378 0.002036623 0.000568921 
Aggregatibacter 
segnis 
LS483443.1 3 2.158273381 0 0 0.001041228 
Capnocytophaga 
ochracea 
CP001632.1 7 5.035971223 0 0.00014568 0.000337159 
Fusobacterium 
canifelinum 
NZ_RQYY00000000.1 0 0 0 0 0 
Neisseria 
flavescens 
LAEI00000000.1 0 0 0 0 0 
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Operational 
Taxonomic Unit 
Accession or 
Assembly Number 
TAS 
Count 
TAS % 
Corrected 
Abundance 
of TAS in 
Oral 1 
Corrected 
Abundance 
of TAS in 
Oral 2 
Corrected 
Abundance 
of TAS in 
Oral 3 
Corynebacterium 
matruchotii 
ACEB00000000.1 0 0 0 0 0 
Prevotella 
intermedia 
CP030094.1 0 0 0 0 0 
Gemella 
morbillorum 
LS483440.1 1 0.71942446 8.16137E-06 2.54094E-05 0.000192379 
Kingella 
denitrificans 
AEWV00000000.1 0 0 0 0 0 
Fusobacterium 
nucleatum 
AE009951.2 9 6.474820144 0.001277021 0.000559733 0.002936262 
Fusobacterium 
periodonticum 
CP028108.1 12 8.633093525 8.11473E-05 0 0.001093076 
Campylobacter 
showae 
UWOJ00000000.1 0 0 0 0 0 
Rothia aeria AP017895.1 6 4.316546763 0.000116824 0 0.00048024 
Streptococcus 
sanguinis 
LS483346.1 5 3.597122302 0.002098637 0.000715093 0.000611278 
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Operational 
Taxonomic Unit 
Accession or 
Assembly Number 
TAS 
Count 
TAS % 
Corrected 
Abundance 
of TAS in 
Oral 1 
Corrected 
Abundance 
of TAS in 
Oral 2 
Corrected 
Abundance 
of TAS in 
Oral 3 
Gemella 
sanguinis 
PNGT00000000.1 0 0 0 0 0 
Veillonella 
atypica 
CP020566.1 7 5.035971223 6.61071E-05 0 1.18997E-05 
Streptococcus 
gordonii 
LS483375.1 4 2.877697842 0.001116009 0 3.39993E-05 
Streptococcus 
mutans 
LS483349.1 7 5.035971223 0.002277021 0.00023546 0 
Porphyromonas 
catoniae 
AMEQ00000000.1 0 0 0 0 0 
Neisseria 
elongata 
CP031255.1 4 2.877697842 0.000331118 0.000144229 5.60988E-05 
Aggregatibacter 
aphrophilus 
LS483485.1 2 1.438848921 0.000294276 0 0.000251878 
Alloprevotella 
rava 
ACZK00000000.1 0 0 0 0 0 
Veillonella 
parvula 
CP019721.1 0 0 0 0 0 
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Operational 
Taxonomic Unit 
Accession or 
Assembly Number 
TAS 
Count 
TAS % 
Corrected 
Abundance 
of TAS in 
Oral 1 
Corrected 
Abundance 
of TAS in 
Oral 2 
Corrected 
Abundance 
of TAS in 
Oral 3 
Streptococcus 
salivarius 
CP013216.1 5 3.597122302 0.000704792 0.000237154 0 
Granulicatella 
elegans 
NZ_KI391971.1 9 6.474820144 0.001091291 0.000622893 0.000332768 
Haemophilus 
parainfluenzae 
FQ312002.1 1 0.71942446 0.000901481 0.000385255 7.47984E-05 
Granulicatella 
adiacens 
NZ_ACKZ00000000.1 0 0 0 0 0 
Actinobacillus 
minor 
ACQL01 1 0.71942446 4.54705E-06 0.000335888 0 
Haemophilus 
haemolyticus 
LS483458.1 6 4.316546763 1.18923E-05 0.00349488 0.000194646 
Neisseria 
mucosa 
CP028150.1 2 1.438848921 0.001651627 0.000143261 0.001901409 
Streptococcus 
mitis 
NC_013853.1 9 6.474820144 0.010968527 0.032255403 0.00346665 
Total Total 139 100 0.024430118 0.043276785 0.014198518 
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Table 3-4: denotes the molecular abundance of the Toxin Antitoxin Systems in relation to the gene counts. 
Operational 
Taxonomic 
Units 
Accession or 
Assembly Number 
Genome 
Size 
Gene 
Count 
Molecular 
Abundance 
of TAS in 
Oral 1 
Molecular 
Abundance 
of TAS in 
Oral 2 
Molecular 
Abundance 
of TAS in 
Oral 3 
Molecular 
Abundance 
of TAS in 
the Oral 
Microbiome 
Capnocytophaga 
leadbetteri 
CP022384.1 2,504,023 2,253 1.33217E-05 0 8.94977E-06 0.001775411 
Lautropia 
mirabilis 
LR134378.1 3,172,010 2,595 0 0 0 0 
Rothia 
dentocariosa 
CP002280.1 2,492,820 2,217 2.0117E-05 3.21655E-05 6.82132E-06 0.00360848 
Haemophilus 
influenzae 
LS483480.1 1,846,600 1,863 2.87065E-06 0.000106455 2.68575E-05 0.005904455 
Actinomyces oris CP014232.1 3,104,690 2,459 4.82955E-05 0.000115124 3.21594E-05 0.00650671 
Aggregatibacter 
segnis 
LS483443.1 1,965,660 1,896 0 0 7.63347E-05 0.001582278 
Capnocytophaga 
ochracea 
CP001632.1 2,658,650 2,171 0 9.32731E-06 2.15869E-05 0.003224321 
Fusobacterium 
canifelinum 
NZ_RQYY00000000.1 2,224,460 2,204 0 0 0 0 
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Operational 
Taxonomic 
Units 
Accession or 
Assembly Number 
Genome 
Size 
Gene 
Count 
Molecular 
Abundance 
of TAS in 
Oral 1 
Molecular 
Abundance 
of TAS in 
Oral 2 
Molecular 
Abundance 
of TAS in 
Oral 3 
Molecular 
Abundance 
of TAS in 
the Oral 
Microbiome 
Neisseria 
flavescens 
LAEI00000000.1 2,291,790 1,994 0 0 0 0 
Corynebacterium 
matruchotii 
ACEB00000000.1 2,867,410 3,144 0 0 0 0 
Prevotella 
intermedia 
CP030094.1 2,777,800 1,762 0 0 0 0 
Gemella 
morbillorum 
LS483440.1 1,756,930 1,656 6.85042E-07 2.13279E-06 1.61478E-05 0.000603865 
Kingella 
denitrificans 
AEWV00000000.1 2,220,450 2,522 0 0 0 0 
Fusobacterium 
nucleatum 
AE009951.2 2,408,530 2,067 8.58761E-05 3.76405E-05 0.000197455 0.004354136 
Fusobacterium 
periodonticum 
CP028108.1 2,477,380 2,540 4.44074E-06 0 5.9818E-05 0.004724409 
Campylobacter 
showae 
UWOJ00000000.1 2,213,800 2,392 0 0 0 0 
Rothia aeria AP017895.1 2,603,190 2,799 5.80156E-06 0 2.3849E-05 0.002143623 
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Operational 
Taxonomic 
Units 
Accession or 
Assembly Number 
Genome 
Size 
Gene 
Count 
Molecular 
Abundance 
of TAS in 
Oral 1 
Molecular 
Abundance 
of TAS in 
Oral 2 
Molecular 
Abundance 
of TAS in 
Oral 3 
Molecular 
Abundance 
of TAS in 
the Oral 
Microbiome 
Streptococcus 
sanguinis 
LS483346.1 2,361,220 2,314 0.000126063 4.2955E-05 3.6719E-05 0.002160761 
Gemella 
sanguinis 
PNGT00000000.1 1,836,490 1,893 0 0 0 0 
Veillonella 
atypica 
CP020566.1 2,071,950 1,887 4.86957E-06 0 8.76558E-07 0.003709592 
Streptococcus 
gordonii 
LS483375.1 2,190,540 2,051 7.56339E-05 0 2.30419E-06 0.001950268 
Streptococcus 
mutans 
LS483349.1 1,962,000 1,885 0.000167908 1.73629E-05 0 0.003713528 
Porphyromonas 
catoniae 
AMEQ00000000.1 2,070,830 1,853 0 0 0 0 
Neisseria 
elongata 
CP031255.1 2,397,850 2,574 1.78809E-05 7.78856E-06 3.02942E-06 0.001554002 
Aggregatibacter 
aphrophilus 
LS483485.1 2,332,870 2,097 1.95061E-05 0 1.66958E-05 0.000953743 
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Operational 
Taxonomic 
Units 
Accession or 
Assembly Number 
Genome 
Size 
Gene 
Count 
Molecular 
Abundance 
of TAS in 
Oral 1 
Molecular 
Abundance 
of TAS in 
Oral 2 
Molecular 
Abundance 
of TAS in 
Oral 3 
Molecular 
Abundance 
of TAS in 
the Oral 
Microbiome 
Alloprevotella 
rava 
ACZK00000000.1 2,593,870 2,177 0 0 0 0 
Veillonella 
parvula 
CP019721.1 2,142,200 2,036 0 0 0 0 
Streptococcus 
salivarius 
CP013216.1 2,236,020 1,903 5.14798E-05 1.73224E-05 0 0.00262743 
Granulicatella 
elegans 
NZ_KI391971.1 1,743,360 1,629 9.31182E-05 5.31505E-05 2.83946E-05 0.005524862 
Haemophilus 
parainfluenzae 
FQ312002.1 2,074,140 1,993 6.2873E-05 2.68692E-05 5.21675E-06 0.000501756 
Granulicatella 
adiacens 
NZ_ACKZ00000000.1 1,947,170 1,889 0 0 0 0 
Actinobacillus 
minor 
ACQL01 2,276,210 2,411 2.62148E-07 1.93648E-05 0 0.000414766 
Haemophilus 
haemolyticus 
LS483458.1 1,914,630 1,774 9.31807E-07 0.000273838 1.52513E-05 0.003382187 
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Operational 
Taxonomic 
Units 
Accession or 
Assembly Number 
Genome 
Size 
Gene 
Count 
Molecular 
Abundance 
of TAS in 
Oral 1 
Molecular 
Abundance 
of TAS in 
Oral 2 
Molecular 
Abundance 
of TAS in 
Oral 3 
Molecular 
Abundance 
of TAS in 
the Oral 
Microbiome 
Neisseria 
mucosa 
CP028150.1 2,492,650 2,734 8.39708E-05 7.28355E-06 9.667E-05 0.000731529 
Streptococcus 
mitis 
NC_013853.1 1,989,190 2,002 0.000761551 0.002239511 0.000240691 0.004495504 
Total 
Accession or Assembly 
Number 
80,219,383 75,636 0.001647457 0.00300829 0.000915829 0.066147616 
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Figure 3-34: represents a histogram to visualize the frequencies of the chromosomal type II toxin 
antitoxin systems predicted in the human oral microbiome.  
96 
 
 
Figure 3-35: A pie chart that visualizes the frequencies of the Toxin Antitoxin Systems families 
predicted in the human oral microbiome. 
 
 
Figure 3-36: A pie chart shows the percentages of each family of the type II Toxin Antitoxin 
Systems in each of the Operational Taxonomic Units used in this study from the human oral 
microbiome. 
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Figure 3-37: A pie chart visualizes the corrected abundance of the type II toxin antitoxin systems 
as represented by each taxon that are used for the analysis from the human oral microbiome. 
 
Figure 3-38: A pie chart visualizes the corrected abundance of the type II toxin antitoxin systems 
as represented by each taxon in oral 1 sample that are used for the analysis from the human oral 
microbiome. 
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Figure 3-39: A pie chart visualizes the corrected abundance of the type II toxin antitoxin systems 
as represented by each taxon in oral 2 sample that are used for the analysis from the human oral 
microbiome. 
 
Figure 3-40: A pie chart visualizes the corrected abundance of the type II toxin antitoxin systems 
as represented by each taxon in oral 3 sample that are used for the analysis from the oral 
microbiome. 
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Figure 3-41: A pie chart visualizes the molecular abundance of the type II toxin antitoxin systems 
as represented by each taxon that are used for the analysis from the human oral microbiome.
 
 
Figure 3-42: A pie chart visualizes the molecular abundance of the type II toxin antitoxin systems 
as represented by each taxon from oral 1 sample that are used for the analysis from the human oral 
microbiome. 
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Figure 3-43 A pie chart visualizes the molecular abundance of the type II toxin antitoxin systems 
as represented by each taxon from oral 2 sample that are used for the analysis from the human oral 
microbiome. 
 
Figure 3-44: A pie chart visualizes the molecular abundance of the type II toxin antitoxin systems as 
represented by each taxon from oral 3 sample that are used for the analysis from the human oral microbiome. 
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Figure 3-45: A heatmap visualizes the frequencies of the Type II Toxin Antitoxin Systems 
predicted in each Operational Taxonomic Unit for the taxa used in the analysis for the human oral 
microbiome. 
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Figure 3-46: A Circos map that visualizes the frequencies of the Type II Toxin Antitoxin Systems 
predicted in each Operational Taxonomic Unit for the taxa used in the analysis for the human oral 
microbiome. The bands connect the toxin-antitoxin genes with their respective species. Thickness 
of the bands represents the frequency. 
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Figure 3-47: A directed protein-protein interaction network visualizes cross talk of the 
chromosomal Type II Toxin Antitoxin Systems that are predicted in the human oral microbiome. 
The edges thickness corresponds to the frequencies of the toxin-antitoxin interactions.  
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Table 3-5: The closeness and degree centralities of the protein-protein interaction network 
depicted in Figure 3-47. 
Toxin Antitoxin System Degree Closeness 
HTH 44 0.000794 
RelE 30 0.000893 
GNAT 29 0.001239 
RelB 25 0.000794 
VapC 14 0.000985 
Phd 12 0.000794 
HipA 11 0.00084 
MNT 10 0.000866 
HicA 9 0.00084 
HicB 8 0.000794 
YoeB 8 0.000866 
AcrR 7 0.000794 
Fido 7 0.000866 
HEPN 7 0.000794 
ImmA/IrrE 7 0.000816 
MazE 6 0.000794 
MazF 5 0.00084 
RHH 5 0.000794 
START 4 0.000866 
VapB 4 0.000794 
HigB 3 0.00084 
HigA 2 0.000794 
LysR 2 0.000794 
MarR 2 0.000794 
ParD 2 0.000794 
PezT 2 0.000816 
YefM 2 0.000794 
AraC 1 0.000794 
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Toxin Antitoxin System Degree Closeness 
Bro 1 0.000816 
CcdA 1 0.000794 
FmhB 1 0.000816 
HxlR 1 0.000794 
LsrR 1 0.000794 
MerR 1 0.000794 
PerR 1 0.000794 
Rrf2 1 0.000794 
 
 
Table 3-6: The molecular diversity of the type II toxin antitoxin systems predicted in the oral 
microbiome. TAS stands for Toxin Antitoxin Systems. OM stands for Oral Microbiome.  
Diversi
ty 
Index 
Berger-
Parker 
index 
Margale
f index 
Simpson 
index λ 
Simpson 
index D 
Simpson 
index Dr 
Shannon 
index 
Pielou 
index 
 d dMa λ D Dr He J Je 
TAS in 
OM 
6.318181
818 
6.574714
12 
0.066903
878 
0.933096
122 
14.94681
677 
3.038007
498 
0.835171
282 
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3.4. Evolutionary and Phylogenetic Analysis 
During population bottlenecks in dynamic environments, like the oral microbiome, the 
stress response and Horizontal Gene Transfer play critical roles (Koonin, 2016; L. Liu et al., 2012; 
Pinilla-Redondo et al., 2018) The fact that one genetic system has both capabilities for stress 
response and modulating horizontal transfer is quite unique from the evolutionary point of view. 
To expand, the protein-protein interactions is believed to be evolved from promiscuous 
intermediates that enables it for the “mixing and matching” phenomenon among different families 
and super-families of the toxins and the antitoxins (Aakre et al., 2015; Gillis & Pavlidis, 2012; 
Goeders & Van Melderen, 2014) This is visualized by making a phylogenetic analysis of all the 
toxin and antitoxin families (see appendix). The results show a mosaic nature where nearly 
different families of different species are not clustered in a clade. By evaluating the evolutionary 
grades, it emphasizes the para-speciation style of the oral microbiome (Flintoft, 2013) This means 
that the genetic drift is prominent where genetic variations are extensive which drives the 
exaptation and provide background for adaptation (Harms et al., 2017) Under extreme stress, 
natural selection is the driving force (Martinez Jose L., 2009) However, in benevolent quasi 
stressful nature, the genetic drift mediated by the altruistic selfish systems is probably the main 
drive force for evolution. For example, neither the HTH-containing genes and GNAT containing 
genes are not clustered together nor the species are clustered together. Moreover, the divergence 
timing of the phylogenetic analysis was close, yet showed different evolutionary rates as measured 
by the molecular clock test. The tests of molecular clocks using the Maximum Likelihood method 
showed lnL Parameters With Clock equals to -104601.156 297 43.851 and Without Clock equals 
to -102026.798 573 16.3. The null hypothesis of equal evolutionary rate throughout the tree was 
rejected at a 5% significance level (P = 0.000E+000). This demote the notion of lateral gene 
transfer of the chromosomal type II toxin antitoxin systems as agreed in the literature (Harms et 
al., 2018c)  
Molecular allometry analysis is an analysis to compare the genome size, coding genes and 
the Toxin Antitoxin Systems (Figure 3-48 and Figure 3-49). The results demonstrate the 
persistence and maintenance of the TAS throughout all genome sizes despite the natural decline 
in the number of coding genes as the genome size decreases. The impact of the chromosomal type 
II toxin antitoxin systems in the evolution of the oral microbiome is one of the questions that need 
further investigations to make us appreciate the vast functionality of the TAS. 
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Figure 3-48: represents Pearson’s correlation with regression analysis for the genome size for all 
genomes used in this study against the number of gene coding sequences for each respective 
genome. The analysis has R square value of 0.4729. The line equation is Y = 0.0006787*X + 
605.4. The deviation from zero is significant with P value <0.0001. CDS stands for CoDing 
Sequences. 
 
 
Figure 3-49: represents Pearson’s correlation with regression analysis for the genome size for all 
genomes used in this study against the number of predicted chromosomal type II toxin antitoxin 
systems for each respective genome. The analysis has R square value of 0.00418. The line equation 
is Y = 7.743e-007*X + 2.197. The deviation from zero is insignificant with p value equals to 
0.7121 implying a slope of near zero value of 7.743e-007 ± 2.08e-006. TAS stands for Toxin 
Antitoxin Systems. 
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4. CONCLUSION 
The predictions of potentially novel chromosomal type II toxin antitoxin systems in the 
oral microbiome had opened questions more than just resolved ones. There have been 278 
sequences that are revealed that are putatively functional due to the similarity in the domain 
architecture. This highlights the need in better functional prediction tools that can sense small 
protein coding genes. The distribution of the toxin antitoxin systems throughout the species in the 
oral microbiome is magnitude. Uneven intra-genomic and inter-genomic distribution as well as 
abundance are evident all over the microbial communities in the buccal cavity. The cross-talk 
network of the toxin antitoxin systems is, probably, shaping the co-evolutions that affects the 
bacterial adaptations.  
Experimental validations for the predicted novel toxin antitoxin systems is a logical step. 
Yet, the functional analysis assays are difficult. The ectopic expression of proteins affects the 
fitness of the host bacterium. Thus, it is always debatable to assess the cytotoxicity of the protein 
that is attenuated by another co-expressed protein. The research group that first experimentally 
tested the toxin antitoxin systems published recent paper that antagonizes their methodology 
expressing this challenge in the functional assay (Song & Wood, 2018b)  
On the other hand, this strikingly valuable system is a core for designing genetic networks 
of synthetic organisms. This could be applied in the post-antibiotic era where clinician could use 
organisms of beneficial characters addicted as a tool for competing against pathogens instead of 
the chemotherapy (Rugbjerg, Sarup-Lytzen, Nagy, & Sommer, 2018) The overall value for such 
endeavor is the ice-berg of understanding how the nature hold the answer when it comes to 
surviving communicable, as well as non-communicable, diseases.  
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APPENDIX 
 
S1 table: This table contains the abundance data for all unique Operational Taxonomic Units 
assigned in the oral microbiome analysis 
Genus Species Oral 1 Oral 2 Oral 3 
Other Other 0.00035653512
6813 
0.0 0.00295368620
038 
g__Actinomyces s__cardiffensis 0.0 0.0 0.00029536862
0038 
g__Actinomyces s__dentalis-
orihominis 
0.0 0.0 0.00277646502
836 
g__Actinomyces s__georgiae 0.0 0.0 0.00498188405
797 
g__Actinomyces s__gerencseria
e 
0.00084271939
0649 
0.0 0.0 
g__Actinomyces s__israelii 0.0 0.0 0.00167375551
355 
g__Actinomyces s__massiliensi
s 
0.00106960538
044 
0.0 0.00098456206
6793 
g__Actinomyces s__meyeri-
odontolyticus 
0.00149096507
576 
0.0 0.0 
g__Actinomyces s__naeslundii 0.00764929908
435 
0.0 0.01313405797
1 
g__Actinomyces s__naeslundii-
oris 
0.00312778543
068 
0.0 0.00354442344
045 
g__Actinomyces s__odontolytic
us 
0.0 0.0 0.00604521109
011 
g__Actinomyces s__oris 0.00429462766
388 
0.0 0.00112240075
614 
g__Actinomyces s__oris-
viscosus 
0.0 0.01769316155
94 
0.0 
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g__Actinomyces s__sp4769 0.00405153553
197 
0.0 0.0 
g__Actinomyces s__viscosus 0.00118304837
533 
0.0 0.0 
g__NA s__sp4816 0.00330605299
408 
0.0 0.0 
g__Bifidobacterium s__adolescenti
s 
0.0 0.0 0.00031505986
1374 
g__Bifidobacterium s__angulatum 0.0 0.0 0.00027567737
8702 
g__Bifidobacterium s__ruminantiu
m 
0.0 0.00037000908
2041 
0.00027567737
8702 
g__Corynebacteriu
m 
s__durum 0.00056721497
4475 
0.00148003632
816 
0.00500157529
931 
g__Corynebacteriu
m 
s__matruchotii 0.00619074629
284 
0.00689562380
168 
0.01697385003
15 
g__Rothia s__aeria 0.00270642573
535 
0.0 0.01112555135
48 
g__Rothia s__dentocarios
a 
0.00557491289
199 
0.00891385515
826 
0.00189035916
824 
g__Rothia s__mucilagino
sa 
0.00093995624
3416 
0.0 0.00112240075
614 
g__Propionibacteriu
m 
s__propionicu
m 
0.00097236852
7672 
0.00151367351
744 
0.00057104599
874 
g__Propionibacteriu
m 
s__sp7795 0.0 0.0 0.00064981096
4083 
g__Atopobium s__parvulum 0.0 0.0 0.00151622558
286 
g__Olsenella s__uli 0.0 0.0 0.00049228103
3396 
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g__Bacteroides s__fragilis 0.0 0.00104275286
757 
0.00086641461
8778 
g__Porphyromonas s__catoniae 0.00337087756
26 
0.0 0.02939902331
44 
g__Porphyromonas s__endodontal
is 
0.0 0.0 0.00679347826
087 
g__Porphyromonas s__sp13364-
sp13375 
0.01003160197
71 
0.0 0.0 
g__Porphyromonas s__sp13375 0.01531480431
08 
0.00450738336
305 
0.0 
g__Porphyromonas s__sp13380 0.0 0.00322917017
054 
0.00275677378
702 
g__Tannerella s__forsythia 0.0 0.00080729254
2635 
0.00515910522
999 
g__Alloprevotella s__rava 0.0 0.0 0.00055135475
7404 
g__Alloprevotella s__sp13491 0.04164978526
86 
0.02135961519
06 
0.03711798991
81 
g__Alloprevotella s__sp13512-
sp13517 
0.00191232477
109 
0.0 0.00250078764
965 
g__Alloprevotella s__sp13514 0.0 0.0 0.00864445494
644 
g__Alloprevotella s__tannerae 0.0 0.0 0.00385948330
183 
g__NA s__sp13865 0.0 0.0 0.01451244486
45 
g__NA s__sp13879 0.0 0.0 0.00127993068
683 
g__NA s__sp13918 0.0 0.0 0.00096487082
5457 
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g__NA s__sp13920 0.0 0.0 0.00047258979
206 
g__NA s__sp13921 0.0 0.0 0.00133900441
084 
g__Paraprevotella s__clara 0.0 0.0 0.00108301827
347 
g__Prevotella s__baroniae 0.0 0.0 0.00055135475
7404 
g__Prevotella s__copri 0.0 0.0 0.00070888468
8091 
g__Prevotella s__histicola-
jejuni 
0.0 0.0 0.00452898550
725 
g__Prevotella s__intermedia 0.0 0.0 0.01874606175
17 
g__Prevotella s__loescheii 0.00051859654
8092 
0.0 0.00578922495
274 
g__Prevotella s__marshii 0.0 0.0 0.00049228103
3396 
g__Prevotella s__melaninoge
nica 
0.00042135969
5325 
0.0 0.00222511027
095 
g__Prevotella s__micans 0.0 0.0 0.00122085696
282 
g__Prevotella s__nanceiensis 0.00341949598
898 
0.00074001816
4082 
0.00039382482
6717 
g__Prevotella s__nigrescens 0.00022688598
979 
0.0 0.00224480151
229 
g__Prevotella s__oris 0.0 0.0 0.00027567737
8702 
g__Prevotella s__pallens 0.00090754395
9161 
0.0 0.0 
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g__Prevotella s__pleuritidis 0.0 0.0 0.00053166351
6068 
g__Prevotella s__saccharolyt
ica 
0.0 0.0 0.00232356647
763 
g__Prevotella s__shahii 0.0 0.0 0.00066950220
5419 
g__Prevotella s__veroralis 0.00050239040
5964 
0.0 0.0 
g__NA s__sp14445 0.0 0.0 0.00033475110
271 
g__Bergeyella s__cardium 0.00042135969
5325 
0.0 0.00063011972
2747 
g__Bergeyella s__sp16466 0.0 0.00067274378
5529 
0.0 
g__Bergeyella s__sp16471 0.00468357507
495 
0.00087456692
1188 
0.00220541902
962 
g__Capnocytophaga s__gingivalis 0.00243092131
918 
0.0 0.00543478260
87 
g__Capnocytophaga s__granulosa 0.00032412284
2557 
0.00380100238
824 
0.00878229363
579 
g__Capnocytophaga s__haemolytic
a 
0.00050239040
5964 
0.0 0.0 
g__Capnocytophaga s__leadbetteri 0.00750344380
52 
0.0 0.00504095778
198 
g__Capnocytophaga s__ochracea 0.0 0.00289279827
778 
0.00669502205
419 
g__Capnocytophaga s__sp16491 0.00046997812
1708 
0.0 0.00120116572
149 
g__Capnocytophaga s__sp16511 0.00333846527
834 
0.00043728346
0594 
0.00527725267
801 
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g__Capnocytophaga s__sp16514 0.00948059314
48 
0.0 0.01476843100
19 
g__Capnocytophaga s__sp16515 0.00037274126
8941 
0.0 0.00456836798
992 
g__NA s__sp19416 0.0 0.0 0.00049228103
3396 
g__NA s__sp19423 0.0 0.0 0.00120116572
149 
g__Olivibacter s__jilunii 0.0 0.00053819502
8423 
0.00027567737
8702 
g__Gemella s__haemolysa
ns-sanguinis-
taiwanensis 
0.02140831375
09 
0.06182515389
01 
0.01681632010
08 
g__Gemella s__morbilloru
m 
0.00113442994
895 
0.00353190487
403 
0.02674070573
41 
g__Abiotrophia s__sp28088 0.0 0.0 0.00504095778
198 
g__Granulicatella s__adiacens 0.01437484806
74 
0.00642470315
18 
0.00238264020
164 
g__Granulicatella s__elegans 0.01685438781
3 
0.00962023613
307 
0.00513941398
866 
g__Lactobacillus s__fermentum 0.0 0.00121093881
395 
0.00049228103
3396 
g__Streptococcus s__NA 0.16940280366
3 
0.49816677318
4 
0.05354048519
22 
g__Streptococcus s__anginosus 0.0 0.0 0.00076795841
2098 
g__Streptococcus s__anginosus-
constellatus-
intermedius 
0.00050239040
5964 
0.0 0.00088610586
0113 
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g__Streptococcus s__gordonii 0.03878129811
2 
0.0 0.00118147448
015 
g__Streptococcus s__intermediu
s 
0.00032412284
2557 
0.0 0.0 
g__Streptococcus s__mutans 0.04521513653
67 
0.00467556930
943 
0.0 
g__Streptococcus s__salivarius-
vestibularis 
0.01959322583
26 
0.00659288909
819 
0.0 
g__Streptococcus s__sanguinis 0.05834211166
03 
0.01987957886
24 
0.01699354127
28 
g__Streptococcus s__sinensis 0.0 0.0 0.00474558916
194 
g__Parvimonas s__micra 0.0 0.0 0.00208727158
16 
g__Mogibacterium s__neglectum 0.0 0.0 0.00131931316
95 
g__NA s__sp31630 0.0 0.0 0.00084672337
7442 
g__NA s__sp31635 0.0 0.0 0.00023629489
603 
g__NA s__sp31682 0.0 0.0 0.00037413358
5381 
g__Butyrivibrio s__sp32116 0.0 0.0 0.00078764965
3434 
g__Catonella s__morbi 0.00030791670
0429 
0.0 0.00342627599
244 
g__Johnsonella s__ignava 0.0 0.00087456692
1188 
0.0 
g__Johnsonella s__sp32278 0.0 0.00104275286
757 
0.00511972274
732 
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g__Johnsonella s__sp32283 0.0 0.0 0.00049228103
3396 
g__Johnsonella s__sp32285 0.0 0.00070638097
4806 
0.0 
g__Lachnoanaeroba
culum 
s__saburreum 0.0 0.00074001816
4082 
0.00277646502
836 
g__Lachnoanaeroba
culum 
s__sp32292 0.0 0.0 0.00161468178
954 
g__Lachnoanaeroba
culum 
s__sp32293 0.0 0.0 0.00704946439
824 
g__Lachnoanaeroba
culum 
s__umeaense 0.00059962725
8731 
0.0 0.00324905482
042 
g__NA s__rectale 0.0 0.00131185038
178 
0.00070888468
8091 
g__NA s__sp33423 0.0 0.0 0.00029536862
0038 
g__Oribacterium s__sp33063 0.0 0.00057183221
77 
0.0 
g__NA s__sp30555 0.00025929827
4046 
0.0 0.0 
g__Peptococcus s__sp34118 0.0 0.0 0.00448960302
457 
g__Filifactor s__alocis 0.0 0.0 0.00057104599
874 
g__Peptoclostridium s__sp34347 0.0 0.0 0.00212665406
427 
g__Peptoclostridium s__sp34351 0.0 0.0 0.00206758034
026 
g__Peptostreptococc
us 
s__anaerobius-
stomatis 
0.0 0.0 0.00490311909
263 
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g__NA s__sp35348 0.0 0.0 0.00181159420
29 
g__NA s__sp35352 0.0 0.0 0.00112240075
614 
g__Solobacterium s__moorei 0.0 0.0 0.00108301827
347 
g__Dialister s__invisus 0.0 0.00107639005
685 
0.00224480151
229 
g__Selenomonas s__artemidis 0.00027550441
6174 
0.0 0.00232356647
763 
g__Selenomonas s__infelix 0.00055100883
2347 
0.0 0.00567107750
473 
g__Selenomonas s__noxia 0.0 0.0 0.00218572778
828 
g__Selenomonas s__sp37070 0.0 0.0 0.00116178323
882 
g__Selenomonas s__sp37070-
sp37072 
0.0 0.0 0.00175252047
889 
g__Selenomonas s__sp37072 0.0 0.0 0.00043320730
9389 
g__Veillonella s__atypica 0.00131269751
236 
0.0 0.0 
g__Veillonella s__atypica-
parvula 
0.0 0.0 0.00023629489
603 
g__Veillonella s__denticariosi 0.0 0.00581923374
483 
0.0 
g__Veillonella s__denticariosi
-parvula-
tobetsuensis 
0.00341949598
898 
0.0 0.0 
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g__Veillonella s__parvula 0.07984766226
4 
0.00686198661
24 
0.05434782608
7 
g__Veillonella s__sp37198 0.03374118791
02 
0.02226781930
1 
0.00082703213
6106 
g__Veillonella s__tobetsuensi
s 
0.0 0.00581923374
483 
0.00248109640
832 
g__Fusobacterium s__canifelinu
m-nucleatum 
0.01262458471
76 
0.00773655353
359 
0.01975031505
99 
g__Fusobacterium s__nucleatum 0.00709829025
201 
0.00090820411
0465 
0.02392485822
31 
g__Fusobacterium s__nucleatum-
periodonticum 
0.0 0.0 0.00167375551
355 
g__Fusobacterium s__periodontic
um 
0.00093995624
3416 
0.0 0.01098771266
54 
g__Fusobacterium s__sp37444 0.0 0.00228732887
08 
0.0 
g__Leptotrichia s__buccalis 0.00218782918
726 
0.0 0.00527725267
801 
g__Leptotrichia s__buccalis-
hofstadii 
0.0 0.0 0.00322936357
908 
g__Leptotrichia s__hofstadii 0.0 0.0 0.00157529930
687 
g__Leptotrichia s__shahii 0.00372741268
941 
0.00225369168
152 
0.00185097668
557 
g__Leptotrichia s__sp37510 0.00019447370
5534 
0.0 0.0 
g__Leptotrichia s__sp37518 0.00831375091
16 
0.00174913384
238 
0.01795841209
83 
g__Leptotrichia s__trevisanii 0.00087513167
4905 
0.0 0.0 
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g__Leptotrichia s__wadei 0.00095616238
5544 
0.0 0.0 
g__Streptobacillus s__hongkonge
nsis 
0.0 0.00090820411
0465 
0.0 
g__NA s__sp38230 0.0 0.0 0.00555293005
671 
g__NA s__sp19816 0.00051859654
8092 
0.00050455783
9147 
0.01466997479
52 
g__Lautropia s__mirabilis 0.00478081192
772 
0.00568468498
772 
0.00897920604
915 
g__Comamonas s__sp48939 0.00058342111
6603 
0.0 0.00124054820
416 
g__Eikenella s__corrodens 0.00056721497
4475 
0.0 0.00580891619
408 
g__Kingella s__denitrifican
s 
0.00338708370
472 
0.0 0.00921550094
518 
g__Kingella s__oralis 0.00262539502
471 
0.00077365535
3359 
0.00098456206
6793 
g__Neisseria s__bacilliform
is 
0.00097236852
7672 
0.0 0.0 
g__Neisseria s__cinerea 0.00847581233
287 
0.00319553298
126 
0.00061042848
1411 
g__Neisseria s__elongata 0.01150636091
08 
0.00501194120
219 
0.00194943289
225 
g__Neisseria s__flavescens 0.0 0.00575195936
628 
0.01317344045
37 
g__Neisseria s__macacae-
mucosa-sicca 
0.11431812657 0.00370009082
041 
0.13214792060
5 
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g__Neisseria s__mucosa-
perflava-
subflava 
0.00046997812
1708 
0.00625651720
542 
0.0 
g__Neisseria s__oralis 0.00048618426
3836 
0.00669380066
602 
0.00129962192
817 
g__Neisseria s__shayeganii 0.0 0.0 0.00364287964
713 
g__Neisseria s__sp49957 0.00064824568
5115 
0.0 0.0 
g__Simonsiella s__muelleri 0.0 0.0 0.00025598613
7366 
g__Bilophila s__wadsworthi
a 
0.0 0.0 0.00041351606
8053 
g__Campylobacter s__concisus 0.00354914512
6 
0.0 0.00419423440
454 
g__Campylobacter s__curvus 0.0 0.0 0.00031505986
1374 
g__Campylobacter s__gracilis 0.00108581152
257 
0.0 0.00076795841
2098 
g__Campylobacter s__rectus-
showae 
0.00118304837
533 
0.00151367351
744 
0.01047574039
07 
g__Cardiobacterium s__hominis 0.00066445182
7243 
0.0 0.00163437303
088 
g__Cardiobacterium s__valvarum 0.00034032898
4685 
0.0 0.00023629489
603 
g__Escherichia-
Shigella 
s__coli 0.0 0.00090820411
0465 
0.00063011972
2747 
g__Actinobacillus s__sp62066 0.00063203954
2987 
0.04668841871
57 
0.0 
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g__Aggregatibacter s__aphrophilu
s 
0.02045215136
54 
0.0 0.01750551354
76 
g__Aggregatibacter s__segnis 0.0 0.0 0.04824354127
28 
g__Aggregatibacter s__sp62087 0.00034032898
4685 
0.00578559655
555 
0.01205103969
75 
g__Haemophilus s__haemolytic
us 
0.00027550441
6174 
0.08096471458
84 
0.00450929426
591 
g__Haemophilus s__haemolytic
us-influenzae 
0.00048618426
3836 
0.01802953345
22 
0.00454867674
858 
g__Haemophilus s__haemolytic
us-quentini 
0.00037274126
8941 
0.0 0.0 
g__Haemophilus s__influenzae 0.0 0.0 0.00137838689
351 
g__Haemophilus s__parainfluen
zae 
0.12530589093
3 
0.05355040532
81 
0.01039697542
53 
g__Haemophilus s__pittmaniae 0.0 0.00050455783
9147 
0.00206758034
026 
g__*Saccharimonas s__sp65946 0.0 0.0 0.00066950220
5419 
g__*Saccharimonas s__sp65955 0.0 0.0 0.00409577819
786 
g__*Saccharimonas s__sp65958 0.0 0.0 0.00096487082
5457 
g__*Saccharimonas s__sp65962 0.0 0.0 0.00823093887
839 
g__NA s__sp65941 0.00046997812
1708 
0.0 0.00427299936
988 
g__NA s__sp66013 0.0 0.0 0.00240233144
297 
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g__NA s__sp66034 0.00021067984
7662 
0.0 0.00133900441
084 
g__NA s__sp66108 0.0 0.00117730162
468 
0.0 
g__NA s__sp66127 0.0 0.0 0.01435491493
38 
g__NA s__sp66606 0.0 0.0 0.00163437303
088 
g__NA s__sp66623 0.0 0.00067274378
5529 
0.0 
g__NA s__sp66675 0.0 0.0 0.00102394454
946 
g__NA s__sp66707 0.0 0.0 0.00031505986
1374 
g__Treponema s__denticola 0.0 0.0 0.00057104599
874 
g__Treponema s__maltophilu
m 
0.0 0.0 0.00037413358
5381 
g__Treponema s__medium 0.0 0.0 0.00057104599
874 
g__Treponema s__medium-
vincentii 
0.0 0.0 0.00055135475
7404 
g__Treponema s__socranskii 0.0 0.0 0.00151622558
286 
g__Treponema s__sp66800 0.0 0.0 0.00029536862
0038 
g__Treponema s__vincentii 0.0 0.0 0.00135869565
217 
g__Fretibacterium s__sp67092 0.0 0.0 0.00035444234
4045 
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g__NA s__sp67855 0.0 0.0 0.00039382482
6717 
 
 

















